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IDENTIFICATION OF THE WINGS APART TRANSCRIPTIONAL UNIT IN
DROSOPHILA MELANOGASTER
by
Ginny R. Morriss
Bachelor of Science, Biology, Gonzaga University
Doctor of Philosophy, Biology, University of New Mexico

ABSTRACT
Muscle development is an evolutionarily conserved process. Mechanisms
that govern the development of specific muscles in invertebrates can inform our
understanding of how vertebrate muscles form. Understanding these processes
allows us to translate developmental mechanisms to disease pathogenesis, as
similar genes and developmental processes are affected by these diseases. In
this dissertation, CG14614 is identified as the gene responsible for the wings
apart phenotype in Drosophila melanogaster. This mutation leads to a loss of the
adult jump muscle (TDT) in most cases and a greater than 60% reduction in
muscle fibers in its least severe form. wap mutants fail to properly form
neuromuscular junctions to the TDT, resulting in degeneration of the muscle.
Regulation of Myocyte enhancer factor 2 (Mef2) expression in the
developing mesoderm, which gives rise to somatic, visceral, and cardiac muscle,
by the transcription factors Twist and Mad was also investigated. Our results
indicate these are both involved in regulation of the Mef2 enhancer but additional
complexity exists in its regulation that remains to be fully elucidated.
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INTRODUCTION
The study of myogenesis is critically important to understand the function
and maintenance of specific muscles, failure of which can lead to muscular
dystrophies. These diseases are primarily characterized by skeletal muscle
wasting and weakness of varying distribution and severity (Campbell, 1995 and
Emery, 2002). Such diseases can result from specific genetic defects common
to all muscle cell nuclei, yet in many cases selectively affect individual muscles
throughout the body (Lamminen, 1990). The selective effects on different
muscles or muscle groups make management of the disease in specific
individuals dependent on the type and severity of dystrophy (Emery, 2002).
Mutations in specific genes associated with muscular dystrophies have been
identified and protein products from these genes are being analyzed in several
animal models (Campbell, 1995). This research has shown that common
understanding of the molecules and mechanisms involved in muscular
dystrophies has been oversimplified and further analyses are necessary to
understand the disease mechanisms (Emery, 2002).
The mechanisms involved in invertebrate muscle development are similar
to those for vertebrate muscle formation, making the animal model Drosophila
melanogaster well suited for studies of myogenesis (Baylies and Michelson,
2001). In flies, the basic patterning and specification of the somatic, or skeletal,
musculature is similar for all muscle fibers. Moreover, early embryonic
myogenesis in Drosophila is completed within a few hours (Bate, 1990). These
facts, alongside the utility of Drosophila to apply a genetic approach to the study
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of biological processes, make this system highly amenable to uncovering basic
and broadly relevant aspects of muscle development.
The mechanisms of Drosophila muscle development occur as a series of
consecutive events. The outcome of each event is usually the measure through
which the investigator assesses the extent of myogenesis in wild-type and
mutant combinations.
Prior to formation of the somatic musculature, the mesoderm must first be
specified. This specification of this germ layer is determined by expression of the
dorsal (FBgn0260632) group genes along the dorsoventral axis of the embryo,
which leads to activation of genes such as twist (FBgn0003900) and snail
(FBgn0003448, Leptin, 1991, and Jiang et al., 1991). twist and snail are
expressed in cells of the ventral side of the embryo. The snail expressing cells
give rise to the presumptive mesoderm that invaginates immediately upon
reaching a critical threshold of twist expression (Leptin et al., 1992). This first
phase of mesoderm invagination is achieved in less than twenty minutes and
forms a tube of cells through a process of cell shape changes, creating what is
known as the ventral furrow (Kam et al., 1991). Formation of the mesoderm
occurs when cells from the presumptive mesoderm tube disperse and spread
into a single layer of cells over the ventral ectoderm (Leptin, et al., 1991). At this
point, snail expression is not longer detected, but twist expression persists
(Kosman et al., 1991).
Following specification, the mesoderm becomes segmented along both
the dorsoventral axis and the anteroposterior axis of the embryo. The gradient of
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Dorsal protein established at the onset of embryogenesis along with ectodermal
signal induction by decapentaplegic (Dpp, FBgn0000490) and wingless (wg,
FBgn0004009) signaling leads to activation of genes necessary for dorsoventral
segmentation of the mesoderm. High concentrations of Dorsal protein are found
at the ventral side of the embryo and activate genes such as twi. Dpp is required
for induction of the dorsal mesoderm segregation by activating genes like
bagpipe (bap, FBgn0004862) and maintaining levels of tinman (tin,
FBgn0004110) dorsally and repressing ventrally expressed genes, (reviewed in
Maqbool and Jagla, 2007). The signal induction allows the dorsal mesoderm to
form the midgut visceral mesoderm, dorsal muscles, and heart (Azpiazu and
Frasch, 1993, Bodmer, 1993, Azpiazu et al., 1996). This regional dorsoventral
subdivision of the mesoderm is conserved from invertebrates and vertebrates
(reviewed in Azpiazu and Frasch 1993).
After segmentation of the dorsoventral compartments, the mesoderm is
organized into parasegmental units with anterior and posterior portions adopting
different developmental fates (Azpiazu et al., 1996). Cells in the posterior portion
of the parasegments express high levels of twist, ultimately leading to formation
of the somatic musculature (Azpiazu et al. 1996, Baylies and Bate, 1996,
Castanon et al., 2001, and Furlong et al., 2001) by activation of myogenic
regulators such as Myocyte enhancer factor 2 (Mef2, FBgn0011656) (Lilly et al.,
1995). A small population of high Twist-expressing cells postpones differentiation
and is set aside for adult muscle development during pupal metamorphosis.
These cells are situated at very specific locations, associated with the peripheral

3

nerves of the abdomen and imaginal discs of the thorax, and prespecify the
pattern of the adult musculature (reviewed in Roy and VijayRaghavan, 1999). In
the remainder of these cells, twist expression decreases and allows for
differentiation of the embryonic musculature (Baylies and Bate, 1996).
Following subdivision of the mesoderm, embryonic skeletal muscle
development initiates upon specification of a unique founder cell (FC) for each
skeletal muscle fiber, and the genetic segregation of that cell from unspecified
fusion-competent myoblasts (FCMs) within the mesoderm (Bate, 1990). FCs are
specified by the Ras signaling pathway (Artero et al., 2004, Stute et al., 2004)
and are differentiated from FCMs by expression of specific genetic markers, such
as Kin of Irre/Dumbfounded (FBgn0028369), Roughest/Irregular Chiasm
(FBgn0003285), and Rolling Pebbles/Antisocial (FBgn0041096). The FCs then
attract the unspecified FCMs to the site of muscle formation, for fusion to
generate precursors of the individual muscles of the somatic musculature
(reviewed in Chen and Olson, 2004). The FCs are critical determinants of muscle
fate. It is widely thought that the FC is responsible for conferring upon the
resulting muscle many of the characteristics unique to that muscle: sites of
muscle attachment to the cuticle, orientation of the muscle in the embryo, and
muscle size (Rushton et al., 1995).
Following specification of FCs and FCMs, myoblast fusion is mediated by
genetic factors governing orientation, adhesion, and eventually fusion of the cells
to form myotubes (reviewed in Haralalka et al. 2010). The fusion process
includes FC-specific markers as well as FCM-specific markers, such as Sticks
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and Stones (FBgn0024189), Hibris (FBgn0029082), and Lame Duck
(FBgn0039039) (Artero et al., 2004). Other markers expressed during myoblast
fusion are molecules of the Rac GTPase signaling pathway and the Ras activator
myoblast city (FBgn0015513, Laurin et al., 2008), Loner (FBgn0026179), kette
(FBgn0011771, Menon et al., 2005), and blown fuse (FBgn0004133, Schroter et
al., 2004). Multiple rounds of fusion between FCs and FCMs are required for
growth of muscles in the embryo (Bate, 1990, Menon et al., 2005). Cues from the
overlying ectoderm, such as secretion of Dpp and wg proteins are also
necessary for specification of cell type, myoblast fusion and differentiation (Bate,
1990, Rushton et al., 1995, Currie and Bate, 1991, and Baylies et al., 1995).
Specific muscle gene sets are selectively activated in the individual
myoblasts and myotubes by myogenic regulatory proteins such as MEF2
(Sandmann et al., 2006), including the contractile proteins Myosin heavy chain,
Troponins I, T, and C, and muscle-specific actins (Arbeitman et al., 2002, Lin et
al., 1996, Kelly et al., 2002, and Kelly Tanaka et al., 2008). Accumulation of
these contractile proteins, or their mRNA transcripts is indicative of terminal
muscle differentiation and are expressed synchronously with genes expressed in
the central nervous system (Arbeitman et al. 2002).
During the larval stage, muscles specified in the embryo undergo a
profound degree of hypertrophy, without overt addition of new myoblasts, nor of
nuclear division within the muscles syncitium (Demontis and Perrimon, 2009).
Also occurring during the larval stage is the active proliferation of twistexpressing cells. These cells form precursors of adult muscles (Bate et al.,
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1991). The precursors for the adult head and thorax are stored in the larval
imaginal discs and will contribute to the adult-specific muscle pattern during
pupal development (Bate et al., 1991, Rivlin et al., 2000, and reviewed in Roy
and VijayRaghavan, 1999).
The pattern of adult muscles bears little resemblance to the pattern of
larval muscles. In order to form the adult muscles, at metamorphosis most larval
muscles histolyze and adult muscles are formed de novo by migration and fusion
of adult muscle precursor cells (Currie and Bate, 1991, Fernandes et al., 1991).
Within these migrating populations, the new adult muscles develop in much the
same manner as is observed for embryonic/larval muscles: founder cells are
specified early during the pupal stage and myoblast fusion occurs, presumably
through a mechanism similar to that defined for the embryo (Rivlin et al., 2000,
Dutta et al., 2004, Atreya and Fernandes, 2008).
The nervous system plays a crucial role in the formation and patterning of
adult muscles (Fernandes and Keshishian, 2004) but not in embryonic muscles
(Broadie and Bate, 1993). Adult muscle development proceeds in parallel with
neuronal restructuring during metamorphosis allowing one to interact with and
influence the other (Fernandes and VijayRaghavan, 1993). In the absence of
innervation, founder cell markers of the dorsal longitudinal muscles are lost
around the time fusion would occur and the proliferation of myoblasts is reduced.
It is unclear whether this occurs for other muscle types. Fusion of myoblasts is
initiated when the developing neuron is denervated, however, muscle
development cannot be sustained (reviewed in Roy and VijayRaghavan, 1999).
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Adult muscles that develop de novo following histolysis of larval muscles are
more sensitive to denervation than adult muscles formed by fusion of myoblasts
to larval muscle scaffolds, such as the dorsal longitudinal muscles (Fernandes
and Keshishian, 1998, Fernandes and Keshishian, 2004).
The final pattern of adult muscles is far more complex than that of the
embryo (reviewed in Bernstein et al., 2003). While each individual embryonic
muscle is composed of a single syncytial fiber, adult muscles are composed of
multiple myofibers (reviewed in Baylies et al. 1998). The muscles of the embryo
are arranged in a repeated segmental pattern with thirty muscles per
hemisegment. By contrast, the adult musculature contains muscles that are
larger and can span multiple segments. In addition to the differences in size and
fiber number, the musculature of the Drosophila embryo and adult differ by the
relative importance of innervation for proper muscle specification, the role of the
epidermis in establishing muscle attachments and guiding myoblast migration to
proper sites of development, and the role of hormone signaling in specifying the
identity of the muscles (reviewed in Roy and VijayRaghavan, 1999). The adult fly
is characterized by a vast diversity in muscle types, which differ from each other
ultrastructurally, physiologically, and at the level of gene expression. Since each
muscle of the adult fly has its own unique identity, in spite of undergoing a similar
myogenic program to other muscles, it is important to study the mechanisms by
which specific muscles are formed.
The study presented in Chapter 1 of this dissertation aims to further
elucidate the mechanisms that are important for proper formation of the Tergal

7

Depressor of Trochanter (TDT or "jump") muscle in Drosophila. Specifically, the
study aims to identify the gene that is affected by a mutation called wings apart
(wap) that causes loss of the TDT. Both the genetic basis of the wap mutation
and the phenotypic consequences of this mutation are explored. In addition, the
mechanism by which the mutation causes loss of the TDT in adult flies is
examined.
Chapter 2 focuses on the regulation of the Mef2 gene in early mesodermal
development. Although much is known about how this myogenic regulator is itself
regulated, direct regulators at the earliest stages of development are yet to be
fully characterized. This chapter assesses the potential combinatorial roles of the
candidate transcription factors Twist and Mad on regulation of the early Mef2
enhancer.
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CHAPTER 1

IDENTIFICATION OF CG14614 AS THE TRASCRIPTIONAL UNIT OF THE
WINGS APART GENE IN DROSOPHILA

9

Abstract
The wings apart (wap, FBgn0004000) phenotype is due to a semi-lethal
mutation located on the proximal X chromosome, mapped to region 20A. The
wap mutation results in loss of the TDT. Prior to my study, it was unknown what
transcription unit is mutated to produce the observed wap phenotype, nor which
process of TDT development is affected by this mutation. In this study,
complementation mapping and RNAi knockdown technology were used to
identify CG14614 (FBgn0031186) as the annotated gene model affected by the
wap mutation. CG14614 encodes a WD40 repeat protein homologous to the
vertebrate wdr68 gene found in skeletal muscle. Results of the RNAi knockdown
also allowed for identification of CG14619 (FBgn0031187) as the annotated gene
model affected by the intro mutation. Analysis of TDT development in wap
mutants indicated that TDT-specific founder cells are specified early in
development but are later lost. The neuron that innervates the TDT reaches its
target in wap mutants but neuromuscular junctions do not form properly. Insights
from this study can help us elucidate mechanisms of neuromuscular
development and facilitate understanding of neuromuscular diseases that may
result from mis-expression of muscle-specific or neuron-specific genes.
Introduction
The degree to which many muscle diseases impact muscles often differs
between distinct subsets of muscles, and some muscle diseases affect only
specific muscle types (Tixier et al. 2010). Although as many as 25 genes have
been implicated in congenital and degenerative muscle diseases, there remain
some muscle diseases for which causative mutant genes are unidentified (Guyon
10

et al. 2007). It is well known that morphologically and functionally distinct subsets
of muscles arise from a uniform pool of mesodermal cells and are regulated by
similar genes and developmental mechanisms (Roy and VijayRaghavan, 1999).
It is, therefore, important to understand how distinct muscle subsets are properly
formed to better understand the genetic defects that lead to muscle diseases.
Muscle development is well conserved from insects to mammals
(reviewed in Buckingham, 2006) and the basic structure of muscle fibers is also
conserved from insects to mammals (Schulz et al., 1991). Furthermore, different
subtypes of human muscle diseases are affected by mutations in genes with
muscle specific-orthologs in Drosophila (Tixier, et al 2010). For these reasons,
research using the model organism Drosophila melanogaster can provide insight
into the basic mechanisms of muscle formation and patterning in more complex
animals, such as vertebrates.
Two sets of muscles are formed during Drosophila development and serve
different purposes throughout the fly life cycle. The embryonic musculature
histolyzes at the onset of metamorphosis at which time the adult musculature is
formed. The adult muscles are more complex and sophisticated than embryonic
muscles (Fernandes et al., 2005) and more closely resemble those of vertebrate
muscle systems (reviewed in Maqbool and Jagla, 2007). For example, adult
muscles in Drosophila often are composed of multiple individual fibers; in
addition, some adult muscles have been shown to require innervation for their
normal development. The majority of information available regarding adult
muscle development is based on studies of the thoracic musculature, including
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the indirect flight muscles (IFMs) and the Tergal Depressor of Trochanter (TDT)
(Roy and VijayRaghavan, 1999).
The TDT or “jump” muscle in adult Drosophila is necessary for the escape
response (Nachtigall and Wilson, 1967) and is stimulated by excitation of the
giant fiber system (Allen et al., 2000). During early metamorphosis, after
histolysis of larval muscles, two populations of twist-expressing adepithelial
myoblasts from the T2 leg imaginal disc migrate to the site of TDT myogenesis.
The early developing TDT consists of 12-13 closely packed imaginal pioneer (IP
or founder) cells (identified by elongated shape and large nuclei) surrounded by
many small myoblasts (Rivlin et al., 2000). As fusion of founders and myoblasts
proceeds, the TDT elongates dorsoventrally and makes contact with the
epidermal cells on the dorsal side of the animal (Rivlin et al., 2000). At 24 hours
after puparium formation (APF), the TDT appears as a group of fibers
surrounding a core of mitotic myoblasts with unfused mitotic myoblasts located at
the dorsal end (Rivlin et al., 2000).
The mature TDT spans the dorsoventral axis of the adult thoracic cavity
(Miller, 1950) between the DVM I and DVM II muscles (Fernandes and
VijayRaghavan, 1993) and attaches to the dorsal notum of the second leg tendon
(Miller, 1950, referenced by Rivlin et al., 2000). It is innervated by the Posterior
Dorsal Mesothoracic Nerve (PDMN), which is restructured from the larval
Intersegmental Nerve (ISN) branching off of the ventral ganglion (Fernandes and
VijayRaghavan, 1993).
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The TDT is a tubular muscle comprised of 26-28 large and 4 small fibers
organized into a rosette pattern, but can be drastically altered by defects in the
genetic program specifying the TDT. Jaramillo et al. (Jaramillo et al. 2009)
showed that components of the TGF-β signaling pathway are involved in
regulating the specification of TDT-specific founder cells and subsequently the
number of muscle fibers found in the mature TDT. Similarly, the vertebrate TGFβ molecule myostatin regulates fiber number. In addition to its role in the
development of muscle fibers, the TGF-β pathway also influences multiple
tissues in a context-dependent manner (reviewed in Kollias and McDermott,
2008).
The TGF-β signaling pathway is also required for proper wing
morphogenesis (Khalsa et al., 1998) and signaling events are heightened within
the presumptive wing crossveins (Ralston and Blair, 2005). Since components of
the TGF-β signaling pathway have been shown to modulate developmental
events in both the wing and TDT, mutations in crossvein patterning genes were
examined to determine if these genes are components of the TGF-β pathway
and if these genes play a role in specification of the TDT pattern (Cripps,
unpublished data). One such mutant identified is wings apart (wap).
wap is a semi-lethal gene with mutant lethality occurring in the pupal
stage, despite showing no delay in developmental timing (Schalet and Lefevre,
1973). wap escapers become entrapped in the food medium and die shortly after
eclosion (Schalet and Lefevre, 1973). Escapers exhibiting the wap phenotype are
characterized by wings slightly set apart, a darker than normal thorax, and one or
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more additional crossveins between the second and third longitudinal veins of the
adult wings (Schalet, 1972 and Schalet and Lefevre, 1973). Complementation
mapping of polytene X chromosomes using wap alleles, induced by X-rays,
chemicals, and p-element transpositions, indicate wap is localized to the 20A3-4
region of the X chromosome (Lifschytz and Falk, 1968, Lifschytz and Falk, 1969,
and Eeken et al., 1985). It is thought to most likely be between the extra organs
(eo, FBgn0000580) and uncoordinated-like (uncl, FBgn0003951) loci, 20A2 and
20A5, respectively (Schalet, 1972). The exact location of the wap gene had not
previously been definitively mapped to a single transcription unit due to difficulty
in evaluating the proximal end of the X chromosome, most likely because of its
strongly heterochromatic nature, and the large number of transposable elements
in that region (Schalet and Lefevre, 1973, Eeken et al., 1985, and FlyBase
FB2012_03). It is currently unknown what annotated gene model within this
region is responsible for the phenotype associated with wap escapers.
In this study I show that the wap mutation not only affects the patterning of
the wing crossveins but also causes a defect in TDT formation. Many of the wap
mutant escapers completely lack the TDT while a very small percentage of these
escapers exhibit a greater than 60% reduction in the number of muscle fibers.
We also identify CG14614, a WD40 repeat protein, as the transcriptional unit that
is mutated to cause the wap phenotype. In addition, we show that the founder
cells that specify the TDT are present in the wap mutant early in development but
are later lost leading to degeneration of the muscle. This degeneration is shown
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to be due to defects in synaptogenesis at the neuromuscular junctions between
the TDT muscle and the PDM nerve.
Materials and Methods
Drosophila stocks
Drosophila were grown on Carpenter's medium (Carpenter, 1950) at 25oC
unless otherwise specified. Fly stocks used in the X chromosome deficiency
screening, mutation mapping crosses, Gal4 driver lines and X chromosome
duplication screening were obtained from the Bloomington Drosophila Stock
Center, with exception to those noted below. The stock carrying the wap3 allele
was obtained from the Drosophila Genetic Resource Center, Kyoto Institute of
Technology. The Act79B-Gal4 driver was made by Anton Bryantsev
(unpublished). Mary Baylies (Memorial Sloan Kettering Cancer Center, NY)
generously provided the rP298-lacZ transgenic line. UAS-RNAi lines were
obtained from the Vienna Drosophila Stock Center (VDRC), except two UASDIP1 RNAi lines obtained from the Transgenic RNAi Project (TRiP) at Harvard
Medical School.
Deficiency screens
Each genetic cross was composed of equal numbers of virgin females and
males and maintained at 25oC. For deficiency screening with wap alleles, each
mutant allele was crossed with the deficiency lines Df(1)Exel6255 (Exelixis, Inc.),
Df(1)BSC708, Df(1)LB6, Df(1)54, Df(1)DCB1-35c, Df(1)DCB1-35b, and Df(1)R8A
(Schalet and Finnerty, 1968, Schalet and Lefevre, 1973 and Rahman and
Lindsley, 1981). The number of progeny eclosed from each individual cross was
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counted. Comparisons between the total numbers of female progeny with
balancer/mutation genotype and female progeny with the deficiency/mutation
genotype were performed using Student's t-test. Lethality of a combination was
concluded only if crosses with each allele of the mutation resulted in lethality.
Analyses of TDT and wing crossvein phenotypes were performed for both
balancer/wap and deficiency/wap genotypes as described below.
The previously-mentioned deficiency lines were also crossed with each
other to further refine the X chromosome map. These same deficiency lines were
used to map other proximal X chromosome mutations thought to be within the
region spanning 20A to 20C: l(1)G0179, eo16-2-27, eo25, intro3, uncl1, uncl10, soz1,
l(1)20Cb2, l(1)20Cb6, l(1)20Ca1, l(1)20Ca2, and l(1)G1096.
Duplication screens
Virgin females of each mutation used in the deficiency screens were also
crossed with equal numbers of males from X chromosome duplication lines
spanning the region deleted by the Df(1)Exel6255 deficiency. The duplication
lines used in these experiments were Dp(1;3)DC382, Dp(1;3)DC383,
Dp(1;3)DC384, Dp(1;3)DC562, Dp(1;3)DC386, Dp(1;3)DC387, Dp(1;3)DC388,
Dp(1;3)DC389, and Dp(1;3)DC390 (Popodi et al., 2010). Not all combinations of
mutations and duplications were tested against one another since some
mutations are complemented by deficiencies of the duplicated region. For those
duplications tested, the number of eclosing male progeny with the genotype
balancer/Y;duplication/+ were compared with male progeny of the
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mutation/Y;duplication/+ genotype using Student’s t-test to assess the ability of
each duplication tested to rescue the phenotype of the mutations.
To insure that any phenotypic rescue observed in the previous duplication
analysis with wap was not due to rescue of a secondary mutation, lines were
generated that had the genotype Df(1)Exel6255/FM7a;duplication/duplication
and/or Df(1)DCB1-35c/FM7a;duplication/duplication for the each of the following
duplications: Dp(1,3)DC383, Dp(1,3)DC384, Dp(1,3)DC562, Dp(1,3)DC386,
Dp(1,3)DC387, Dp(1,3)DC388, and Dp(1,3)DC389. These lines were crossed
with wap2/Dp(1,y)y+mal171 males. Female FM7a/wap2;duplication/+ progeny were
compared with female deficiency/wap2;duplication/+ progeny to assess whether
the wap mutation can be rescued by the duplications. The TDT and wing
crossvein phenotypes were assessed as described below for rescue by
duplication.
RNAi knock-down
The Gal4/UAS system was utilized for RNAi knockdown experiments
(Brand and Perrimon, 1993). Equal numbers of virgin female and male flies were
allowed to mate three days at 25oC at which point crosses were transferred to
29oC to activate the Gal4 drivers. tub-Gal4 and da-Gal4 were used as ubiquitous
drivers for initial RNAi analysis. To determine tissue specific effects of RNAi
knockdown, Act79B-Gal4 and 1151-Gal4 drivers were used for muscle-specific
knockdown and elav-Gal4 was used for knockdown in the nervous system. UASRNAi lines were utilized for knockdown of DIP1 (VDRC lines 50206, 50207, and
108186 and TRiP lines 35226 and 35333), CG14614 (line 107076), CG14619
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(lines 37929 and 37930), CG14618 (lines 24879 and 47451), CG12576 (lines
51205 and 104261), and Cp110 (lines 24874, 24875, and 101161). RNAi
knockdowns were assessed for viability. TDT formation was assessed by
cryosections of pharate pupae of the pupal lethal knockdowns as described in
the following sections.
Recombination experiment
To obtain flies carrying both the wap mutation and the founder cell-specific
rP298-lacZ transgene (described in Ruiz-Gomez et al., 2000), I performed
recombination crosses. Female FM7i,GFP/wap mutants were crossed with equal
numbers of rP298-lacZ transgenic males. Both the wap2 and wap9 alleles were
used for these crosses. rP298-lacZ/wap female progeny from the F1 generation
were selected as virgins and crossed with FM7i,GFP/Y males. Each female of
the F2 generation was isolated individually as virgins and again crossed with
FM7i,GFP/Y males to establish stable stocks.
Progeny from these crosses were assessed for presence of the wap
mutation by observing the Bar-eye phenotype associated with the FM7i, GFP
balancer. The presence of males with wild-type eye morphology indicated that
the lethal wap mutation could not be present in the generated stock. To screen
for the presence of the rP289-lacZ transgenic marker, two adult flies from each
line positive for the wap mutation were filleted and stained overnight at 37oC in
XGAL solution [1X PBS, 100 mM K4[Fe(CN)6], 100 mM K3[Fe(CN)6], 150 mM
NaCl, 1 mM MgCl2, and 0.2% w/v X-Gal (Sigma)]. Stocks positive for both the
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wap mutation and rP298-lacZ transgene were used in pupal dissections
described below.
Preparation of samples for microscopy
Samples to be analyzed for TDT structure were prepared for paraffin
sectioning according to methods described by Lyons et al. (Lyons et al., 1990),
modified by Cripps et al. (Cripps et al. 1998). Sections were cut at 10 µm and
stained with Hematoxylin and Eosin (Sigma). Stained slides were dehydrated
through 100% ethanol, soaked in xylene, and mounted in Cytoseal-XYL (VWR
Scientific products).
Cryosections were prepared by removing pharate pupae from the pupal
case, embedding in OTC medium and freezing. Sections were cut at 10 µm at 18oC and air dried. Samples were fixed for 8 minutes at room temperature with
3.7% v/v formaldehyde in PBTx [1XPBS, 0.2% v/v Triton-X100, 0.2% w/v
Blocking Agent (Roche)], washed and used for antibody staining as described in
the following section.
For pupal dissections to assess founder cell specification and
neuromuscular junction formation, new white prepupae were selected and aged
until the appropriate time for dissection. Pupal samples were dissected in a
Sylgard-coated petri dish (Dow Corning) and pinned open. Samples were fixed
for 30 min on ice in 5% formaldehyde in 1X PBS, washed in PBTx, then
subjected to blocking and incubated with antibody (described below).
For analysis of the crossveins of the adult wings, wings were removed
from adult flies and stored overnight in 70% (v/v) ethanol. Wings were transferred

19

twice into 100% ethanol and soaked in 100% xylene prior to being mounted in
Cytoseal-XYL (VWR Scientific Products) for imaging.
Immunohistochemistry of prepared samples and imaging
Fixed and washed samples were stained with antibodies as described by
Patel (Patel, 1994) and modified by Molina and Cripps (Molina and Cripps,
2001). Primary antibodies used for cryosections were anti-βPS-integrin 1:10
(Brower et al., 2008) (University of Iowa Developmental Studies Hybridoma
Bank). For pupal dissections, primary antibodies used were mouse anti-βgalactosidase 1:400 (Promega), rabbit anti-MEF2 1:1000 (Lilly et al., 1995)
(provided by Bruce Paterson, NIH), mouse anti-22C10 1:100 (University of Iowa
Developmental Studies Hybridoma Bank), rabbit anti-HRP 1:25 (GenScript), and
mouse anti-Dlg 1:10 (University of Iowa Developmental Studies Hybridoma
Bank). For immunofluorescence of sections, Alexa conjugated (Molecular
Probes) secondary antibodies were mixed with Alexa-488 phalloidin at 1:500
(Molecular Probes) and 2 µg/mL DAPI (Sigma). Alexa-conjugated secondary
antibodies were diluted to 1:2000 for pupal stains.
An Olympus BX-51 stereomicroscope with DIC or fluorescent optics was
used to collect images. Adobe Photoshop was used to compile digitally collected
images into figures.
Results
wings apart (wap) mutants are characterized by three phenotypes
Mutants with defects in the crossveins of the adult wings were examined
to determine if these mutants also exhibit TDT defects since components of
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signaling pathways involved in wing vein development are also involved in proper
TDT development. Mutant thoraces were visualized in paraffin sections cut
horizontally to the muscle axis (unpublished data). One of the mutants analyzed
was the wings apart (wap) mutant that is characterized by three phenotypes
(Figure 1). Figure 1A shows the wing of an adult wild-type fly. In a wild-type wing,
there are five longitudinal veins and two crossveins. By contrast, the wings apart
mutant has supernumerary crossveins located between the second and third
longitudinal veins (arrows in Figure 1B). The TDT of the wild-type fly is organized
in a rosette pattern, between the DVM I and DVM II muscles (Figure 1C). When
paraffin sections of the thoracic muscles were visualized in the wap mutant, we
observed that the TDT is absent while no other thoracic muscles are affected
(asterisk in Figure 1D). In addition to the wing and TDT phenotypes, wap mutants
are semi-lethal as homozygotes (Schalet, 1972) and this semi-lethal phenotype
is observed in heteroallelic combinations of three wap alleles (Figure 1E). Since
the phenotypes are observed in all homozygous lines of wap mutants, as well as
in heteroallelic combinations of the alleles, we can conclude that the phenotypes
all arise from the same mutation.
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Figure 1: The wings apart (wap) mutation is characterized by three phenotypes. (A, B) Wings
from wap escapers (B) have additional crossveins (arrows) between the second and third
longitudinal veins compared with wild-type wings (A). (C, D) The TDT in wild-type flies is located
between the DVM I and DVM II (C). The TDT is absent in wap mutants (asterisk in D). (E)
Compared to wild-type flies, wap heteroallelic mutants exhibit a semi-lethal phenotype, similar to
that of wap homozygous mutants. (*p<0.01, **p<0.001)

wap is located in region 20C in the proximal X chromosome
Mapping of the wap mutations by Lifschytz and Falk suggested that wap is
located on the proximal X chromosome in region 20A3-4 (Lifschytz and Falk,
1968, grey highlighted region in Figure 2). To more precisely localize the
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transcriptional unit affected by the wap mutation, each of the wap mutant alleles
was crossed with the deficiency lines Df(1)Exel6255 (Exelixis Inc.),
Df(1)BSC708, Df(1)LB6, Df(1)54, Df(1)DCB1-35c, Df(1)DCB1-35b, and Df(1)R8A
(Schalet and Finnerty, 1968, Schalet and Lefevre, 1973 and Rahman and
Lindsley, 1981).

Figure 2: wap was previously mapped to region 20A2-3 of the proximal X chromosome.
The map of the proximal X chromosome indicates annotated genes (light blue bars) located
between 19F6 and 20C1 of the X chromosome. The deficiencies used in this study are shown
on the map by the red bars. Deficiencies Df(1)Exel6255 and Df(1)BSC708 are molecularly
mapped. Other deficiencies were added to the map based on computed cytological location,
but have undefined breakpoints (denoted by pink bars). Lower blue bars indicate the positions
of molecularly defined duplication lines used in this study. The grey highlighted region
denotes the region where wap was initially mapped. (Image was adapted from the map on
FlyBase (FB2012_02).)

Results from complementation mapping of wap alleles with the deficiency
lines indicated in Figure 2 (red bars) indicate that the deficiency lines
Df(1)BSC708, Df(1)LB6, and Df(1)R8A complement wap. The data in Figure 3A
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represent aggregate results for the wap2 and wap9 alleles. The wap3 allele was
not included in the aggregated results but exhibited significantly reduced viability
with the Df(1)BSC708 and Df(1)R8A deficiencies (data not shown). These two
deficiencies nevertheless complemented wap, since wap2 and wap9 show strong
viability in trans to the deletions. It is likely that the wap3 chromosome contains a
second lethal mutation on it that is uncovered by Df(1)BSC708. The lethality
observed for the Df(1)R8A deficiency with wap3 was due to the presence of the
Df(1)R36 (Rahman and Lindsley, 1981) deletion on the same chromosome as
the wap3 allele. If data from the wap3 allele is included in the analyses of these
deficiencies, the percentage of eclosed females heterozygous for wap and the
Df(1) BSC708 and Df(1)R8A deficiencies decreases to 63.5% and 52.3%,
respectively, while these data for the other complementation analyses remain
unaffected (data not shown).
There are also four deletion lines, Df(1)Exel6255, Df(1)54, Df(1)DCB135c, and Df(1)DCB1-35b, that are semi-lethal when heterozygous with the wap
mutant (Figure 3A). These data suggest the region proximal to the Df(1)BSC708
deletion and distal to the Df(1)R8A deletion is the region in which wap is located.
To confirm that these escapers show all three wap phenotypes, the wings and
thoraces of females heterozygous for the deficiencies and wap were analyzed by
for the presence of the wing and TDT phenotype characteristic of wap. Those
heterozygous females from the deficiency lines that complemented wap had
normal wings and the TDT was present (Figure B and C, results from
Df(1)BSC708/wap2 shown). The escapers from the semi-lethal heterozygotes
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exhibited an additional crossvein between the second and third longitudinal vein,
characteristic of wap homozygous mutants (Figure 3D). The TDT in almost all of
these heterozygous females was completely absent (Figure 3E, results from
Df(1)Exel6255/wap2). It is important to note that although almost all escapers
lack the TDT muscle, a small percentage of the escapers, 3% (n=64), had a TDT;
however, the muscle exhibited abnormal morphology and a greater than 60%
reduction in the number of fibers compared with a wild-type TDT muscle (10 to
12 fibers in mutants compared with 30-32 fibers in wild-type).
Results of these analyses and previously published work (Lifschytz and
Falk, 1968) suggest that a likely candidate for the wap phenotype is DIP1, as it is
the only gene deleted by all four deficiencies located in region 20A, as long as
we assume that the polytene band annotations to the genome are accurate. We
sought to confirm this result using molecular analysis by sequencing the entire
DIP1 gene in both the wap2 and wap9 alleles. We observed no non-synonymous
amino acid substitutions within the coding region of the wap2 allele relative to the
Drosophila melanogaster reference sequence (FB2012_03) and only a single
variation within the coding region of the wap9 allele (data not shown). It remained
unclear whether this mutation observed in the wap9 allele was significant to the
function of DIP1 or if it was alternatively due to variation in the DIP1 gene among
individual flies. Additionally, we were unable to reproduce the wap phenotypes by
RNAi knockdown of DIP1 when using a number of different RNAi lines, and
different Gal4 drivers (data not shown).
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Figure 3: wap mutations are lethal when heterozygous with four of the tested
deficiencies. (A) Proportion of eclosed females heterozygous for wap and the indicated
deficiencies. Lethality was observed when wap was heterozygous with Df(1)54 (n = 104),
Df(1)Exel6255 (n = 508), Df(1)DCB1-35c (n = 275), and Df(1)DCB1-35b (n = 114). (*p<0.01,
**p<0.001) Df(1)BSC708 (n = 774), Df(1)LB6 (n = 304), and Df(1) R8A (n = 564)
complemented wap. (B, C) Wings and thoraces of wap flies heterozygous with
complementing deficiencies resemble the wild-type phenotype. (D, E) Wings and thoraces of
mutants heterozygous for lethal deficiencies recapitulated the phenotype observed for wap
homozygous mutants. The presence of an additional crossvein (arrow in D) was observed
for with the lethal deficiencies. These deficiencies also resulted in loss of the TDT (asterisk
in E) when heterozygous with wap.

Due to inconsistencies between the initial deficiency mapping of wap and
the molecular analysis of DIP1, we sought to refine our mapping by performing
complementation tests of the deficiencies themselves. This was done based on
the possibility that annotated, computed breakpoints obtained from the FlyBase
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database (FB2012_02) for several of the deficiencies (Df(1)LB6, Df(1)54,
Df(1)DCB1-35c, Df(1)DCB1-35b, and Df(1)R8A) may not be located within the
predicted region (indicated by the map in Figure 2). In this scenario, those genes
located in region 20C1 and that are deleted by Df(1)Exel6255 cannot be ruled
out as candidates for wap. Results found in Table 1 demonstrate
complementation of Df(1)BSC708 and Df(1)LB6 with Df(1)DCB1-35c, suggesting
that the proximal breakpoints for both Df(1)BSC708 and Df(1)LB6 are to the left
(i.e., centromere distal) of the distal breakpoint for Df(1)DCB1-35c. The proximal
breakpoints for Df(1)54 and Df(1)DCB1-35c are left of the distal breakpoint for
Df(1)R8A, as both of these are complemented by the Df(1)R8A deficiency (Table
1, last column). The distal breakpoint of Df(1)R8A is also more proximal than the
proximal breakpoint of Df(1)Exel6255 as inferred from complementation between
these two deficiencies. The Df(1)DCB1-35b deficiency spans the entire region
tested, as previously reported (Schalet and Finnerty, 1968) and does not
complement Df(1)R8A.
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Deficiency mapped
Df(1)DCB1- Df(1)DCB135c
35b
Df(1)R8A
Deficiency/Deficiency Df(1)BSC708 Df(1)LB6 Df(1)54 Df(1)Exel6255
Df(1)BSC708
+
Df(1)LB6
+
+
Df(1)54
+
Df(1)Exel6255
+
Df(1)DCB1-35c
+
Df(1)DCB1-35b
Df(1)R8A
Table 1: Viability of deficiencies mapped to the other deficiencies.
NT indicates the deficiency lines were not crossed.
+ indicates complementation of the deficiencies,
- indicates lethality.
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While the mapping of the deficiencies resolved some of the
inconsistencies in the locations of deficiency breakpoints, it was still not adequate
to completely refine the map of this genetic region. I therefore complementation
mapped additional mutations previously known to be located within the same
region of the proximal X chromosome, for which the corresponding transcriptional
units have yet to be identified from among the annotated gene models. These
mutations are thought to affect predominantly single genes rather than multiple
genes. If the mapping has sufficient resolution, candidate genes for the different
mutants could be inferred (Table 2, mutants arranged according the predicted
order on the chromosome).
The mutant/deficiency complementation data suggested that the locations
of the mutations, relative to each of the other mutations tested, remain in the
original map order, with the exception of l(1)20Ca and l(1)20Cb, for which the
order was switched. However, the regions to which each of these mutations are
located on the chromosome map does change.
The results presented in Table 2 indicate that the mutant l(1)G0179 is
deleted by both Df(1)LB6 and Df(1)54, but not by the other deletions. l(1)G0179
is complemented by Df(1)BSC708 suggesting its actual location on the
chromosome is distal to region 19E7, where the breakpoint of Df(1)BSC708 is
located (based upon annotation of cytological regions relative to annotated
genomic coordinates on FlyBase, FB2012_02). It also suggests that the distal
breakpoint of Df(1)54 extends even further distal to its computed breakpoint of
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19F1 and the mapped breakpoint of Df(1)BSC708, although the exact extent of
the deletion remains unknown.
Table 2 also indicated that the lethal extra organs (eo, FBgn0000580)
mutation lies between the Df(1)BSC708 and Df(1)DCB1-35c deficiencies but is
not complemented by Df(1)LB6, suggesting that the proximal breakpoint for the
Df(1)LB6 deficiency is to the right of the proximal breakpoint for Df(1)BSC708.
The complementation results for the introverted (intro, FBgn0001268)
mutation were very similar to those obtained for the wap mutation (Table 2 and
Figure 3A). For both of these mutants, the mutation was localized to the region
between the proximal breakpoint of Df(1)LB6 and the between the proximal and
distal breakpoints of Df(1)DCB1-35c.
The uncoordinated-like (uncl, FBgn0003951) mutant was complemented
by all the deficiencies except Df(1)54 and Df(1)DCB1-35b. This suggests that the
mutation lies proximal to Df(1)Exel6255 and distal to Df(1)R8A. What is also
suggested by these results is that one breakpoint of the Df(1)54 deficiency must
also be found within the region between the breakpoints of these deficiencies. It
is important to note that results were not consistent between the two uncl alleles
used for the mapping (denoted by the asterisk in Table 2). A condition for lethality
in this analysis is that the deficiency tested must fail to complement all alleles
tested for a specific mutant. The analysis of these mutant alleles indicated that
the uncl1 allele was lethal with all deficiencies except Df(1)LB6, suggesting that
additional mutations may be present in the proximal region of the X chromosome
in uncl1 mutants.
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Both the sozzled (soz, FBgn0001568) and l(1)20Ca (FBgn0001569)
mutants were complemented by all the deficiencies except Df(1)DCB1-35c. This
indicates that the location of these two mutations lies between the breakpoints of
Df(1)Exel6255 and Df(1)R8A and proximal to uncl and the proximal breakpoint of
Df(1)54. Lastly, the l(1)20Cb (FBgn0001570) mutant is complemented by all
deficiencies, except for Df(1)R8A.
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Deficiency/mut
Df(1)BSC708
Df(1)LB6
Df(1)54
Df(1)Exel6255
Df(1)DCB1-35c
Df(1)DCB1-35b
Df(1)R8A

l(1)G0179
+
+
+
NT
+

eo
+
+
+

Mutation mapped
wap
uncl
soz
+
+
+
+
+
+
+
+
+
+
+
+

intro
+
+
+

Table 2: Viability of mutations mapped by deficiencies.
Two alleles of each mutation, except l(1)G0179, intro, and soz, were crossed to each deficiency.
NT indicates the mutation was not tested with the deficiency.
*Two alleles of uncl were tested with inconsistent results between the alleles.

32

l(1)20Cb
+
+
+
+
+
+
-

l(1)20Ca
+
+
+
+
+
+

To provide additional rigor to the deletion mapping data, each mutation
tested in the above experiments was subjected to complementation experiments
using duplication lines (blue bars in Figure 2) to rescue the phenotype observed
in the mutants (Table 3). The duplication lines selected were those that span the
region deleted by the Df(1)Exel6255 deficiency, since this deletion failed to
complement wap; moreover, the breakpoints of this deficiency have been
molecularly mapped. Not all of the duplications were tested with all the
mutations, since the deficiency analysis suggested some mutations cannot be
located in the regions duplicated. The analysis showed that, consistent with our
deficiency screen data, the l(1)G0179, l(1)20Cb, and l(1)20Ca mutations cannot
be rescued by any of the duplication constructs tested.
The eo mutation also could not be rescued by any of the tested
duplications. This could be due to the presence of more than one lethal mutation
on the eo mutant chromosome or perhaps, the entire region required for
expression of the eo gene product or some key regulatory region is not
duplicated by the duplication line being tested. It is not surprising that the uncl
mutation cannot be rescued by any of the duplications since the results from the
deficiency screen suggested that multiple sites on the X chromosome were
affected by the uncl mutation. soz was rescued by the Dp(1;3)DC390 duplication,
refining the location of this gene to the region mapped in the complementation
analysis.
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Duplication/mutation
Dp(1;3)DC382
Dp(1;3)DC383
Dp(1;3)DC384
Dp(1;3)DC562
Dp(1;3)DC386
Dp(1;3)DC387
Dp(1;3)DC388
Dp(1;3)DC389
Dp(1;3)DC390

l(1)G0179
NT
NT
NT
NT
NT
NT

eo
NT

intro
NT
NT
NT
+
-

Mutation mapped
Deficiency/wap
uncl
NT
NT
+
NT
-

wap
+
-

Table 3: Rescue of mutations by X chromosome duplications.
intro and wap are rescued by Dp(1;3)DC389.
soz is rescued by Dp(1;3)DC390.
NT indicates the mutation was not tested with the duplication.

34

soz
+

l(1)20Cb
NT
NT
NT
NT
NT
NT
-

l(1)20Ca
NT
NT
NT
NT
NT
NT
-

Data presented in Table 3 also indicate the ability of Dp(1;3)DC389 to
rescue both intro and wap. This alone suggests that intro and wap are both
located in the 92,593 bp region duplicated by Dp(1;3)DC389. Thus, DIP1 cannot
be the gene responsible for wap, as the deficiency analysis previously
suggested. When we crossed lines of Df(1)Exel6255/FM7a;
Dp(1;3)DC389/Dp(1;3)DC389 with wap2/Dp(1,Y)y+mal171 males, we were able to
rescue Df(1)Exel6255/wap2 females that were lethal in the absence of the
duplication (Figure 4A). We were also able to rescue Df(1)DCB1-35c/wap2
females with the Dp(1;3)DC389 duplication using the same approach; however,
this result is less significant considering that the Df(1)DCB1-35c deficiency can
itself be fully rescued by the Dp(1;3)DC389 duplication (data not shown).
Thoraces from the both Df(1)Exel6255/wap2;Dp(1;3)DC389/+ females and
Df(1)DCB1-35c/wap2;Dp(1;3)DC389/+ female have a wild-type wing phenotype
(Figure 5B, see Figure 1A for comparison) and have a fully formed TDT (Figure
5C, see Figure 1C). A few escapers eclosed from the lines with the
Dp(1;3)DC383, Dp(1;3)DC386, and Dp(1;3)DC388 duplications. These flies were
not considered to be rescued by these duplications as all escapers died shortly
after eclosion, had extra wing veins, and lacked the TDT muscles (data not
shown).

35

2

2

Figure 4: Dp(1;3)DC389 rescues Df(1)Exel6255/wap and Df(1)DCB1-35c/wap
2
2
heterozygotes. (A) Df(1)Exel6255/wap (n = 410) and Df(1)DCB1-35c/wap (n = 234) are
lethal but can be rescued by Dp(1;3)DC389 (n = 53 and n = 108, respectively). (*p<0.01,
**p<0.001) (B, C) Df(1)Exel6255/wap2;Dp(1;3)DC389/+ females have wild-type phenotypes.

Based on the above information, it is necessary to draw a new map of
region 20A to 20C. Figure 5 incorporates all the data obtained from this study
into a new map presenting a clearer picture of the wap location. The map
presented extends the region deleted in Df(1)LB6 beyond the proximal
breakpoint of Df(1)BSC708. Although it remains unclear where the proximal
breakpoint of Df(1)LB6 is located (pink bars in Figure 5), it cannot extend beyond
the touch insensitive larva B (tilB, FBgn0014395) gene as this deficiency can
complement tilB mutations (Kavlie et al. 2010).
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The region deleted by the Df(1)54 deficiency can also be extended such
that the map reflects the proximal breakpoint of this deletion being located
between the proximal breakpoint of Df(1)Exel6255 and the distal breakpoint of
Df(1)R8A and within the region duplicated by Dp(1;3)DC390, but cannot
definitively say where this breakpoint is located. As is the case with the proximal
breakpoints of Df(1)LB6 and Df(1)54, the position of the distal breakpoint of
Df(1)R8A cannot accurately be defined. However, it is clear from the data that
this deletion does not overlap with any of the other deficiencies used in this
screen except for Df(1)DCB1-35b. It was also established that the entire deletion
in the Df(1)DCB1-35c deficiency line is located in the region where the
Dp(1;3)DC389 is located. The location of the distal breakpoint can also be
restricted to the region proximal to tilB since this gene is complemented by
Df(1)DCB1-35c (Kavlie et al. 2010). The regions where the eo, wap, intro, uncl,
soz, and l(1)20Ca mutations are most likely found can be added to this map.
eo is located within the region between the proximal breakpoint of
Df(1)BSC708 and tilB, in which there are three genes—DIP1, CG14621, and
CG14615. The key to identifying what transcriptional unit is affected by this
mutant is to determine the precise molecular coordinates of the Df(1)LB6
proximal breakpoint. uncl, soz, and l(1)20Ca are located proximal to
Dp(1;3)DC389 but further analysis is required to define their precise locations.
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Figure 5: Refined map of the proximal X chromosome. The map from Figure 2 was
redrawn based on the results of mapping experiments. Positions of breakpoints for
Df(1)LB6, Df(1)54, Df(1)DCB1-35c, and Df(1)R8A were adjusted but are still not
molecularly defined. Undefined breakpoint are represented by pink bars. Green bars
indicate the region where mutations must be located.

CG14614 is the gene responsible for the wap phenotype
Both wap and intro are found within the region defined by Df(1)DCB1-35c
and Dp(1;3)DC389. Six genes, CG14614 (FBgn0031186), CG14619
(FBgn0031187), CG14613 (FBgn0031188), CG14618 (FBgn0031189), CG12576
(FBgn0031190), Cp110 (FBgn0031191), and l(1)G1096 (FBgn0027279), are
found in this region. wap was complemented by a l(1)G0196 mutant suggesting
l(1)G0196 is not the gene responsible for the wap phenotype (data not shown).
For the other genes in the region, RNAi was performed to knock down
expression of the products encoded by each gene using the well-established
Drosophila Gal4/UAS system (Brand and Perrimon, 1993). The rationale for this
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experiment was that by individually knocking down expression of each of the
remaining candidate genes, it should be possible to recapitulate the wap
phenotypes when the correct gene is knocked down. I initially carried out the
knockdowns using the constitutively expressed Gal4 lines tub-Gal4 and da-Gal4.
Table 4 lists the genes in the region for which RNAi constructs were
available, along with the results of the knockdown with both the tub-Gal4 (Lee
and Luo, 1999) and da-Gal4 (Dura, 2005.12.4) drivers. Knock down of CG14613
was not tested due to unavailability of an RNAi construct. No lethality was
observed in a CG14618 knock down and the knock down flies had a normal TDT.
This gene was therefore ruled out as a candidate for wap. Viability was also
observed when da-Gal4 was used to knock down CG14619 (line 37929),
CG12576 (line 51205), and Cp110 (all lines). Lethality was observed when daGal4 was used to drive knock down of CG14614 and CG14619 (line 37930). The
tub-Gal4 driver was able to cause lethality when used to knock down CG14614,
CG14619 (both lines), CG12576 (line 104261), and Cp110 (line 101161). All but
one (CG12576) of the lethal tub-Gal4 knockdowns were lethal in the pupal stage.
We were able to rule out CG12576 as a candidate for wap since wap mutants
survive until the pupal stage. This left CG14614, CG14619, CG14613, and
Cp110 as candidates for the gene responsible for the wap phenotype.
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Gene
targeted
CG14614

VDRC Line
number
107076

Off
targets
0

CG14619

37929

23

37930

23

24879
47451
51205
104261
24874
24875
101161

0
0
1
0
0
0
0

CG14618
CG12576
Cp110

tub-Gal4 driver phenotype
pupal lethal,
reduced or absent TDT
pupal lethal,
failure of head eversion
pupal lethal,
failure of head eversion
viable
viable
viable
larval lethal
viable
viable
pupal lethal, normal TDT

Table 4: Genes knocked down by RNAi.
UAS-RNAi lines for the indicated genes were obtained from VDRC stock center.
Genes were tested using both the tub-Gal4 and da-Gal4 drivers.
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da-Gal4 driver phenotype
lethal 2 days post eclosion,
reduced or absent TDT
viable,
normal TDT
pupal lethal,
failure of head eversion
viable, normal TDT
viable, normal TDT
viable, normal TDT
NT
viable, normal TDT
viable, normal TDT
viable, normal TDT

I next wanted to determine if I had reproduced the wap TDT phenotype
with any of the knock down experiments for the remaining candidates. Since
CG14614, CG14619, and Cp110 are all lethal in the pupal stage, pharate pupae
were removed from their pupal cases and cryogenically sectioned to assess the
TDT morphology. Figure 6A is an example of the adult thoracic musculature. The
TDT is positioned on the lateral side of the thorax, between DVMs I and II. The
TDTs of Cp110 and CG14619 knockdown flies developed normally compared
with the wild type flies (Figure 6B and C, arrows). Based on this observation,
both Cp110 and CG14619 can be ruled out as candidates for wap. RNAi knock
down of CG14614 resulted in flies that had absent TDT muscles (asterisk in
Figure 6D) or reduced TDT fiber number (arrows in Figures 6E and 6F). In these
knock downs, like the wap mutants, the majority of the flies analyzed were
missing their TDTs with a few exhibiting a fifty percent or greater reduction in the
number of TDT fibers. There were also some flies that exhibited both
phenotypes, with a reduced phenotype TDT on one side of the thorax and one
missing TDT on the contralateral side. These results strongly suggest that the
gene that is mutated to give rise to the wap phenotype is CG14614.
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Figure 6: Knock down of CG14614 reproduces the TDT phenotype observed in wap mutants. Pharate pupae from RNAi experiments
resulting in pupal semi-lethal phenotype were sectioned cryogenically and stained with phalloidin (green) to label the muscles, βPS-integrin
(red) to visualize membranes, and DAPI (blue) to label nuclei. (A) The TDT (arrow) is positioned between DVM I and DVM II. (C, D) Knock
down of Cp110 and CG14619 with tub-Gal4 did not affect TDT formation. The indirect flight muscles in (C) are clearly affected by the knock
down but the observed disorganization is presumably due to the presence of head structures in the thorax. (D-F) Knock down of CG14614
with tub-Gal4 and da-Gal4 resulted in TDT absence (asterisk in D) or reduced number of TDT fibers (E, F).
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CG14619 is a likely candidate gene mutated in intro mutants
CG14619 was ruled out as a candidate for wap based on the presence of
a normally developed TDT. However, prior to sectioning, there was noticeable
difference in the pupae of these knock downs (Figure 7). While wild-type flies had
three obvious body segments and fully elongated wings and legs (bracket in A')
located in the middle region of the pupa (Figure 7A-7A’’), the knock down of
CG14619 resulted in the presence of only two developed body segments, the
thorax and abdomen, and failure of head eversion (Figure 7B-7B’’). The
phenotype was even more obvious when the pupa was removed from the pupal
case (Figure 7B’’’ compared with wild-type in Figure 7A’’’). This phenotype is
reminiscent of the described pupal phenotype of intro mutants (described as
mutation 23 by Lifschytz and Falk, 1969). In addition to the failure of head
eversion, the wing and leg discs in these knockdowns did not fully elongate and
were located at the top of the pupal case where the thorax is located (brackets in
B').
Since there are a number of off-targets associated with the RNAi lines
used for the CG14619 analysis (see Table 4), I wanted to confirm that my results
were due to knock down of CG14619 and not due to effects of off-target knock
down. Our earlier mapping data suggested that the intro mutation is found within
the 20C1 region we analyzed by RNAi. As the phenotype observed for CG14619
knockdown were similar to the intro phenotype described by Lifschytz and Falk
(1969), we also analyzed the pharate pupal phenotype of intro homozygous
mutants. When the CG14619 knock downs were compared with intro mutants,
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both exhibited the same failure of head eversion and wing and leg elongation
(Figure 7C-7C’’’). These results indicate that CG14619 is the most likely
candidate gene affected by the intro mutation.
In summary for the genetic mapping analysis, I have demonstrated that
the wap gene is located close to the heterochromatin of the proximal X
chromosome, adjacent to other mapped mutations in the region. wap appears to
be allelic to CG14614 based upon the precise recapitulation of the viability and
TDT wap phenotypes when CG14614 was knocked down. The knock down of
CG14614 did not recapitulate the wing vein phenotypes that was observed in a
subset of wap mutants, but since the wing vein phenotype is not fully penetrant, it
is most likely that we have simply yet to sample sufficient flies to observe this
effect. In addition, many of the flies that do eclose fail to expand their wings,
making it difficult to determine if the subtle wing vein defect is present.
Having identified the gene responsible for the wap mutation, I next sought
to determine the basis of the TDT phenotype.
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Figure 7: Knock down of CG14619 recapitulates the phenotype observed in intro
mutants. (A-A’’) Dorsal, ventral, and lateral view of wild-type flies in the pupal cases
shows normal development of the head, wings, and legs in the pupal case. (A’’’) When the
pupa is removed from the pupal case, the fly resembles a fully formed adult. (B-B’’’)
Knockdown of CG14619 results in failure of head eversion and wing and leg extension.
The pupa has only two observable body segments, the abdomen and thorax. (C-C’’’) intro
homozygous mutants exhibit the same phenotypes as those seen in CG14619
knockdowns.
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TDT founder cells are specified early in development in wap mutants but
are later lost
Muscle founder cells are required for proper specification of individual
muscles. Since these cells have all the genetic information to give the muscle its
unique identity, and since the wap mutant phenotype is specific to the TDT, we
hypothesized that TDT-specific founder cells are not specified in wap mutants.
The wap2 and wap9 mutations were recombined with the founder cell duf-lacZ
line (also referred to as rP298) that shows lacZ expression in all muscle founder
cells. Next pupae were dissected at 4 hour intervals beginning at 16 After
Puparium Formation (APF) and flanking the early stages of TDT development
(Fernandes and VijayRaghavan, 1993). Dissected samples were stained for the
myoblast nuclei marker MEF2 (red) and β-Gal expressed by the rP298-lacZ
marker of founder cell nuclei (green). Our results indicated that founder cells
were specified early in development but were later lost (Figure 8).
In 16 hr APF FM7i/rP298-lacZ,wap heterozygous females, although the
founder cells cannot be seen, the TDT is found located between DVM I and DVM
II that were used landmarks for the presumptive location of the TDT (Figure 8A).
In rP298-lacZ,wap/Y mutant males, the developing TDT muscle was present next
to the DVM I (Figure 8B). At 20 hr APF, the TDT in FM7i/rP298-lacZ,wap pupae
have more structured musculature and the presence of founder cells were
evident in the TDT (green labeled cells, Figure 8C). By contrast, the 20 hr APF
rP298-lacZ,wap/Y males had largely reduced staining of TDT-specific founder
cells but did not exhibit a reduction in founder cell staining in the DVMs (Figure

46

8D). In addition to this, the mutant TDT (Figure 8D) is much less structured
compared with the ordered nature of the wild-type TDT (Figure 8C). By 24 hr
APF, the FM7i/rP298-lacZ,wap pupal musculature had a well developed pattern
with the TDT nestled between the DVMs (Figure 8E). By contrast, in the 24 hr
APF mutant rP298-lacZ,wap/Y males, the TDT is completely absent (Figure 8F).
The results of this study demonstrate the requirement for wap early in TDT
development. Although specification and myoblast fusion are initiated in wap
mutants, development cannot be sustained and TDT degeneration occurs. I next
examined the cause for the degeneration of the TDT at so early a stage of
development.
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Figure 8: Founder cells are specified early in development but are later lost in wap
mutants. (A, B) Formation of the TDT at 16 hours APF indicates that development of the
TDT in wild-type (A) and wap mutants (B) is normal at this stage. (C, D) At 20 hours APF,
the developing TDT in wild-type flies (C) is more structured than the TDT of wap mutants
(D). The number of TDT-specific founder cells in the mutant is reduced compared to wildtype, even though there is no reduction in the founder cells of adjacent muscles. (E, F) By 24
hour APF, the mature TDT in wild-type flies (E) is well developed. By contrast, the TDT of
wap mutants is absent (asterisk in F).
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The Posterior Dorsal Mesothoracic Nerve (PDMN) reaches its intended
muscle target, the TDT
My results indicated that the TDT is initially formed early in development
but degenerates due to loss of TDT-specific founder cells. Adult muscle
formation and neuron restructuring proceed in parallel with one another and the
two processes are also dependent on one another. In studies of IFM
development, when neuron restructuring is disrupted, the intended muscle target
degenerates (Fernandes and VijayRaghavan, 1993). For this reason, we
assessed whether the Posterior Dorsal Mesothoracic Nerve (PDMN), which
innervates the TDT, is restructured properly. Since the innervation pattern is first
observed at 18 hours APF and does not change markedly afterwards (Fernandes
and VijayRaghavan, 1993), the correspondence of this process with the time
points at which wap mutant phenotypes were apparent further supported
neuronal defects as a possible mechanism for the wap TDT phenotype.
Therefore, I dissected pupae at this stage from wap/Y males and compared the
innervation pattern (visualized with anti-22C10, marking Futsch expression) with
heterozygous FM7i/wap females. Figure 9 shows a normal innervation pattern for
the TDT indicated by the arrow in the heterozygous FM7i/wap females. The
PDMN reached the TDT in wap/Y mutant male pupae; however, the morphology
of the nerve endings in the mutants differed from those of the heterozygotes. The
nerves appeared to spread over the muscles but the boutons at the
neuromuscular junctions appear to lack the structure observed in the wild-type
neurons.
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To visualize if these neuromuscular junctions (NMJs) are indeed absent in
wap mutants, pupae were again dissected but visualized with anti-HRP (green)
to observe the neurons, and anti-Dlg (red) to stain the muscles and NMJs (Figure
10). In the heterozygous FM7i/wap females, the nerves were visible and the HRP
and Dlg antibodies were co-localized along the muscle. In contrast, the neurons
of the wap/Y mutants were visible but did not make contact with muscles as
indicated by the lack of co-localization of the HRP and Dlg. These results
suggest that the NMJs are not properly formed in wap mutants. Since proper
muscle formation is dependent on interactions between the developing muscles
and nerves, the failure to form neuromuscular junctions may be the mechanism
by which the wap mutation affects TDT development.

Figure 9: The Posterior Dorsal Mesothoracic Nerve (PDMN) is restructured to reach
the TDT. 18 hour APF pupae were dissected and stained with anti-22C10 to label
neurons and adult muscle. The stereotypical branching pattern of the PDMN is indicated
by the arrow in the wild-type pupa. In wap mutant, the PDMN reaches the TDT but the
morphology of the nerve branches does not reflect the characteristic pattern of the
PDMN.
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Figure 10: Neuromuscular junctions (NMJs) are not observed in wap mutants. In
wild-type, the presence of NMJs are visible by the co-localization of HRP (green) and Dlg
(red) indicated by the arrows. There is no co-localization of HRP and Dlg in wap mutants,
indicating the NMJs are not properly formed.

Discussion
Different genes that exhibit similar mutant phenotypes often function within
the same signal transduction pathway. Such signaling pathways require
robustness to resist changes both in the environment and in the cells where the
signaling is taking place. Without such robustness, development does not
proceed normally. Mutants with observable phenotypes typically exhibit a
complete breakdown of the signaling pathways that control proper development
of the affected tissue types (reviewed in Friedman and Perrimon, 2007). Two
distinct cell types, wing crossveins and adult muscles, each require the function
of the same signal transduction networks for proper development (Jaramillo et
al., 2009, Khalsa et al., 1998, Ralston and Blair, 2005). Known mutants with wing
crossvein defects were therefore screened to identify potential defects in the
morphology of the Drosophila jump muscle.
The wings apart mutant analyzed in this study exhibits an observable
phenotype that affects not only the adult wing, but also the viability of the flies
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and the formation of the TDT muscle. The observed TDT phenotype is similar to
that of crossveinless (cv, FBgn0000394) mutants and other TGF-β mutants
(Jaramillo et al., 2009) but does not exhibit the same wing crossvein phenotype
as in those mutants. Since cv mutants that lacked the posterior crossvein of the
adult wing also showed decreased numbers of TDT muscle fibers, and wap
mutants have extra wing crossveins, we initially expected the wap mutants to
have increased fiber number in the TDT. However, the observed downregulation
of TDT formation by the wap mutant can be explained by at least two different
possibilities.
The first possibility is that wap is involved in the TGF-β signaling pathway,
like cv, but may interact with components of the pathway that do not interact with
cv. The TGF-β pathway has many different ligands, different types of receptors,
and various intracellular components that associate with each other in varying
combinations in a context dependent manner (Khalsa et al. 1998). MAN1
(FBgn0034964) protein products antagonize the TGF-β pathway (Wagner et al.,
2010) and MAN1 mutation leads to the presence of ectopic wing crossveins
(Pinto et al., 2008). These mutants do not have an observable muscle defect or
abnormal neuromuscular junctions but affect synaptic transmission, providing
further evidence for context dependence in TGF-β signaling activity.
A second possibility is that, although wap acts on the same tissues as cv
and other TGF-β components, it may be part of a different signaling pathway.
The Epidermal Growth Factor receptor (Egfr, FBgn0003731) pathway is also
required for the proper formation of wing crossveins (Ralston and Blair, 2005)
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and also functions in the formation of muscles (Maqbool and Jagla, 2007).
Angulo et al. (Angulo et al., 2004) show that absent, small, or homeotic discs 2
(ash2, FBgn0000139) represses EGFR signaling. Mutations in ash2 also result in
ectopic wing veins (Angulo et al., 2004) and neural defects (Beltran et al. 2003).
Other options are that wap functions in multiple pathways or act with sets
of genes that are activated multiple times throughout development (Friedman
and Perrimon, 2007). The only way to distinguish among these possibilities is to
identify the transcriptional unit that is mutated to produce the observed
phenotypes. In our initial mapping experiments, two deficiency lines were utilized
that were induced using the FLP recombinase as described in Parks et al. (Parks
et al. 2004) and thus has molecularly mapped breakpoints. The breakpoints for
the other deficiencies were determined by cytogenetic analysis of X-ray induced
deficiencies (Schalet and Finnerty, 1968, Schalet and Lefevre, 1973, and
Rahman and Lindsley, 1981) and computed breakpoints were obtained from
FlyBase (FB2012_02). Due to the presence of intercalating β-heterochromatin
found within the proximal region of the X chromosome and the error commonly
associated with imprecise breakpoint estimates in cytogenetic mapping
(reviewed in Schalet and Lefevre, 1973, and Matthew et al., 2009), assumptions
made based on deletions with cytogenetically determined breakpoints may not
be entirely accurate.
In this study, evidence for such inaccuracy was obtained. For example,
initial mapping based solely on these deficiency chromosomes suggested that
DIP1 was the candidate gene model mutated in wap flies. However, additional
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complementation mapping, using deficiency chromosomes, point mutations and
duplications, and other published results (Kavlie et al. 2010), DIP1 was excluded
as the transcriptional unit for the wap gene. I was unable to definitively map the
breakpoints of the deficiencies and the other mutations used in this study but
closer estimates of the breakpoint and mutation locations were obtained by the
combined conclusions of the cross results. In order to molecularly define the
breakpoints, deep sequencing, using NextGen sequencing techniques, of the X
chromosome in the deficiency lines is necessary. However, the refined mapping
results suggest wap is located within the region between the tilB and l(1)G0196
genes (genomic coordinates X:21,851,573…X:21,889,016.
Using RNAi analysis and the pupal semi-lethality phenotype of wap, I was
able to rule out two of the six genes found in this region, CG14618 and
CG12576. In addition, by characterization of the thoracic muscles in the region,
we were able to determine that the gene responsible for the wap phenotype was
CG14614. CG14614 is lethal in the late pupal stage during which wap mutant
lethality is observed (Schalet, 1972), as well as the period in which wing
crossveins develop (Waddington, 1940).
Temporal expression profiles for CG14614 indicate moderately high to
high expression in the embryonic stages beginning at 0 hours and decreasing
through 16-18 hours (Graveley et al., 2011). Expression returns to moderately
high levels in the late L3 larval stage and maintains this level of expression
through day 3 of the pupal stage (Graveley et al., 2011). Formation of larval and
adult somatic musculature, respectively, and peak expression of clusters of

54

muscle differentiation genes are expressed during these times (Arbeitman et al.,
2002).
CG14614 is a gene that encodes a WD40 repeat domain protein with
orthologs found in organisms ranging from yeast to plants, such as the TTG1
gene that regulates root, shoot, and leaf patterning in Arabidopsis (Walker et al.,
1999, FlyBase, FB2012_02), to vertebrate craniofacial and muscle patterning
genes (Nissen et al., 2006, FlyBase, FB2012_02). WD40 repeat proteins mediate
protein-protein interactions and contain 4-10 repeating units of 44-60 residues
ending in tryptophan and aspartate (WD) (reviewed in Holm et al., 2001 and
reviewed in Suganuma et al., 2008). These repeats form propeller-like structures,
termed β-propellers, created by the folding of four antiparallel β-sheets (reviewed
in Holm et al., 2001). This protein family is known to have roles in signal
transduction, mRNA processing, gene regulation, vesicular trafficking, and
regulation of cell cycle (reviewed in Skurat and Dietrich, 2004 and reviewed in
Suganuma et al., 2008).
One particular vertebrate ortholog for CG14614, is the vertebrate wdr68
gene that is involved in craniofacial patterning in zebrafish (Nissen et al., 2006)
but has also been isolated in rabbit skeletal muscle (Skurat and Dietrich, 2004).
The zebrafish severe craniofacial defect observed in wdr68 mutants can be
rescued by CG14614 suggesting that the function of the wdr68 gene is
conserved in animals from invertebrates to vertebrates, even in developmental
processes not found in the invertebrate animals (Nissen et al., 2006).
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Wdr68 associates with members of the Dual-specificity tyrosine
phosphorylation-regulated kinase gene family, Dyrk1a and Dyrk1b. Dyrk1a plays
a role in phosphorylation of glycogen synthase and is expressed at high levels in
the central nervous system, heart and skeletal muscle (Skurat and Dietrich,
2004). Mutations in Dyrk1a genes in humans and mice are associated with
neurological defects (Martinez de Lagran et al., 2004). Dyrk1b, which is activated
by Rho-GTPase family members, has increased expression in skeletal muscles
and regulates the transition from growth to differentiation. Knockdown in mouse
C2C12 cell lines displays a loss of myogenin expression and leads to failure in
muscle differentiation (Deng et al., 2003). Dyrk1 also has a conserved function
between vertebrates and invertebrates. The Drosophila gene minibrain (mbn) is a
functional ortholog of the vertebrate Dyrk1a and is shown to be required in proper
formation of post-embryonic neurons (Tejedor et al., 1995 and reviewed in
Kinstrie et al., 2006).
The Wdr68/Dyrk1 complex is required for proper differentiation of multiple
tissues in a conserved manner and cellular localization of this complex is
dynamic (reviewed in Nissen et al., 2006). Moreover, given that the WD40
repeats contained in the Wdr68 protein can facilitate protein-protein interactions
(reviewed in Holm et al., 2001), it is possible that the Wdr68/Dyrk1 complex
functions as part of a signaling pathway. It is unknown whether mbn is localized
in the same tissues as wap (CG14614) and whether the two proteins genetically
interact in Drosophila as do their vertebrate homologs. Further analyses such as
in situ hybridization and immunostaining of flies for wap and mbn are necessary
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to resolve whether the gene products are colocalized in the developing adult
muscle or neurons in Drosophila pupae. In addition, much work is needed to
characterize CG14614 in the context of the wap mutation.
Based on our data, CG14614 is the gene that gives rise to the wap
phenotype. In order to confirm these results, rescue of wap by the protein
encoded by CG14614 will be performed. The initial rescue of the wap mutation
was performed using a large duplication of the X chromosome. Since gene
expression of the CG14613 gene was not tested by RNAi, this is a necessary
step to ensure CG14613 is not also involved in the phenotype of the wap
mutation. It would also be interesting to determine if the wap mutation can be
rescued by zebrafish Wdr68 protein in a reciprocal rescue experiment to that
performed by Nissen et al. (Nissen et al., 2006). It is also important to determine
where the wap mutations are located in the CG14614 gene. Sequencing of the
CG14614 gene in the wap mutants is necessary for further analysis of this
mutation, to define its role in muscle development, and to understand its
molecular mode of action.
The RNAi results not only allowed the ubiquitin-specific protease encoding
gene CG14619 to be ruled out as the gene affected by the wap mutation but also
helped identify this gene as the most likely gene responsible for the intro
mutation. At the end of the larval stage, a pulse of ecdysone is released, inducing
pupariation and the onset of metamorphosis (Thummel, 1996). At 12 hours APF,
another pulse of ecdysone is released, resulting in contractions of the abdomen
allowing the prepupa to move posteriorly to make room for the head in the
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anterior end of the pupal case. This contraction creates internal pressure that
causes head eversion and final elongation of the wings and legs (reviewed in
Forier et al., 2003). The pupae from the RNAi knock downs displayed failure of
head eversion. The presence of the head structures can be seen in the thorax
sections in Figure 6. In the phenotype observed in Figure 7 the tubGal4/CG14619 (37929), the pupa is characterized by only two visible body
segments, the abdomen and thorax. The results of tub-Gal4/CG14619 (37930)
RNAi knock down (not shown) were similar to those obtained for line 37929. The
same phenotype can be observed in intro mutants.
This phenotype is reminiscent of the phenotype observed in ecdysoneresponse genes, such as β-FTZ-F1 (FBgn0001078, Fortier et al., 2003), and
cryptocephal (crc, FBgn0000370) (Hewes et al., 2000). In these mutations, head
eversion fails and, in some cases, there is a leg disc elongation defect (Hewes et
al., 2000) that is also observed in CG14619 knockdowns. Before the conclusion
can be made definitively that CG14619 is the most likely gene affected by intro
mutants, rescue of the intro phenotype by expression of CG14619 protein is
necessary. The lines used in this study both had off-target hits to 23 genes other
than CG14619, some of which can also be induced by ecdysone. Whether the
phenotype we are seeing is the result of knockdown of intro or the result of
knockdown of another target is still unknown. While it is possible that the
phenotype observed may be due to off-target hits by the RNAi constructs used,
the recapitulation of the phenotype observed in the intro homozygous mutants
suggest this is unlikely. Another way to address this problem is to knock down
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expression of CG14619 with a different RNAi construct with no off-targets to
determine if the same phenotype is observed. Nevertheless, the potential
function of CG14619 in head eversion identifies it as a possible genetic target of
one of the cryptocephal genes, each of which encodes regulatory proteins.
To determine a mechanism by which wap affects the development of the
TDT, I first analyzed whether TDT-specific founder cells are specified in these
mutants. Founder cells provide the unique identity of individual muscles
Specification of muscle founders is dependent on intrinsic expression of genes
and extrinsic signaling pathways acting on the cells in combinations that are
unique for each specific muscle (reviewed in Maqbool and Jagla, 2007). These
cells can competently form thin muscles at properly specified locations even
when fusion of additional myoblasts fails to occur (Dutta et al., 2004) further
suggesting that these cells are important components of proper muscle
development. When we observed the development of the TDT over time, we
found that the muscles begin to form normally and include the presence of TDTspecific founder cells, marked by expression of the rP298-lacZ transgene. As
development progresses, we observed a loss of founder cells and a subsequent
disorganization of the TDT by 20 hrs APF, followed by degeneration of the TDT
by 24 hrs APF.
Muscle identity is not only determined by founder cell specification, it is
also determined by its innervation pattern. The innervation of a specific muscle is
stereotypical and therefore exhibits a precise and unvarying wiring pattern
(Keshishian, et al., 1996). As development progresses, the growth cones of the
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motor neuron explore the surfaces of myotubes, searching for the correct
synapse partner. To accomplish specific targeting of the motor neuron, cell
surface molecules must be expressed on the founder cells (reviewed in
Keshishian et al., 1996). In the absence of founder cells, defasciculation of axons
is inhibited and neurons do not branch to reach their targets (Landgraf et al.
1999). The final step of innervation of a muscle target is the formation of the
synapse (reviewed by Shishido et al., 1998). Synapse formation requires proper
formation of both the pre-synaptic active zones and differentiation of the postsynaptic muscle (Prokop et al., 1996). Studies involving the dorsoventral muscles
of the adult thorax indicated that ablation of the nerve that innervates these
muscles blocks formation of muscle fibers, even though myoblast fusion was
initiated. These results suggest that interaction between the nerve and its
postsynaptic muscle target are critical for maintenance of the synapse and
therefore for proper formation of the muscle (Fernandes and Keshishian, 1998).
Results from this study show that formation of the PDMN occurs normally
and reaches its target. Morphology of the neuron branches in wap mutants is not
the same as that observed in the wild-type. Based on this morphology, we
determined if the NMJs are properly formed in the mutants. In wild-type pupae,
NMJ formation was observed, however, synapses were not apparent in the wap
mutants. These results suggest the mechanism by which wap affects
development of the TDT is failure of proper motor neuron synapse formation. It is
still necessary to determine whether this effect is due to a defect in the
presynaptic neuron or the postsynaptic muscle. To determine this, tissue specific
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knockdown of the identified wap gene, CG14614 will be performed in the muscle,
using the myoblast 1151-Gal4 driver, and also in the neuron, using the elav-Gal4
driver.
This tissue-specific analysis is crucial to understanding what effect this
gene has on the development of the muscles. Since orthologs of CG14614 and
their interaction partners are found in both skeletal muscle and nerves (Skurat
and Dietrich, 2004), the effect could potentially be on either side of the synapse.
The relevance of understanding the effects of the wap mutation may not
be immediately apparent in terms of the specificity of the Drosophila muscle it
affects. However, this study indicates CG14614 has an evolutionarily conserved
function, which is consistent with the findings that the Drosophila gene can
rescue genetic defects found in vertebrates (Nissen et al., 2006). Thus, this
system may allow us to determine how CG14614 and its vertebrate homologues
function in establishing formation of muscle and neuromuscular junctions.
Insights gleaned from vertebrate models have indicated that muscle
degeneration/atrophy results from improper formation of neuromuscular
junctions, even when neurons reach their intended targets (Williams et al., 2009).
Furthermore, neuromuscular junctions are conserved from flies to humans at the
genetic, molecular, and physiological levels (Lloyd and Taylor, 2010). Nervous
system involvement is frequently found in different muscular dystrophies
(reviewed in Guyon et al., 2007) making it important to study the molecular basis
of these diseases in organisms that can facilitate a basic understanding on the
processes involved.
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CHAPTER 2

TRANSCRIPTIONAL REGULATION OF THE EARLY MESODERMAL MEF2
ENHANCER BY TWIST AND MAD
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Abstract
Mesoderm formation is one of the key events in early development of
organisms from invertebrates to vertebrates, and the resulting germ layer gives
rise to diverse cell fates. Myocyte Enhancer Factor 2 (Mef2) is required for proper
formation of the mesoderm and all lineages of muscle. Expression of Mef2 must
be tightly regulated to ensure precise spatiotemporal activity of the gene
throughout the developmental process. A 1,059 base pair enhancer is required
for proper expression of Mef2 in the developing dorsal mesoderm that eventually
forms the visceral muscle, dorsal somatic muscles, and heart. In this study, we
assess the contributions of the transcription factors Twist and Mad/Medea to
Mef2 expression via this enhancer. Activation of the enhancer requires both
Twist and Mad/Medea binding sites in vivo. Moreover, these transcription factors
can activate the enhancer in tissue culture, although not synergistically. The
transcription factor Dorsal may also interact with this enhancer to facilitate both
activation and repression of Mef2 activity. These studies define the enhancer that
regulates expression of Mef2 in the developing mesoderm and the contributions
of Twist and Mad to enhancer activation. The study also highlights the
complexities of mesodermal Mef2 enhancer activation in vivo.
Introduction
Coordinated inputs of signaling and transcription networks allow for
acquisition of specific cell fates during embryogenesis (Sandmann et al., 2007).
Proper development of the mesoderm is critical for the developing embryos of all
triploblastic animals. The mesoderm is the middle germ layer of the developing
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embryo composed of pluripotent cells that give rise to the somatic, visceral, and
cardiac muscles. Its development is initiated by high nuclear concentrations of
the transcription factor Dorsal in ventral cells of the embryo which, in turn,
activates the twist and snail genes. Activation of twist and snail lead to the
induction of gene expression critical for the maintenance and further
development of mesodermal tissues (Leptin et al., 1991).
Mef2 is activated early in the developing mesoderm and is required for
proper development (Sandmann et al.2007). MEF2 is part of the Myocyte
Enhancer Factor 2 family of transcription factors containing a MADS (MCM1,
Agamous, Deficiens, serum response factor) domain that binds to the regulatory
region of myogenic and muscle structural genes (reviewed in Cripps and Olsen
2002). Mef2 is the only gene known to regulate the entire muscle differentiation
process, including both the spatial and temporal distribution of myogenic cells,
and is expressed in precursors to all muscle lineages. Early in development, it is
expressed throughout the mesoderm.
After gastrulation, MEF2 is also found ubiquitously within the mesoderm
and after the mesoderm layer spreads to the dorsal region, Mef2 is enriched at
the dorsal region of the embryo. This suggests that there is very stringent
regulation of Mef2 in both the early and late stages of development (Nguyen and
Xu 1998). There are at least twelve different upstream enhancers of Mef2 that
direct the differential regulation of this gene in the various tissues and
developmental stages (reviewed in Black and Olson, 1998). One such Mef2
enhancer active early in mesoderm development is regulated by the transcription
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factor Twist (Cripps et al. 1998) and later by the Mad and Medea transcription
factors (Nguyen and Xu 1998). This early mesodermal enhancer is
approximately 4 Kb in length (from position -3564 to +521). A core portion of
this sequence is active in imaginal discs, controlled by a 175 bp region, and
regulates adult somatic muscle precursors. However, the minimal 175-bp
enhancer is not fully active in the embryonic mesoderm (Cripps et al. 1998).
Twist is a basic helix-loop-helix (bHLH) transcription factor that specifically
binds to E-box consensus sequences (CANNTG) and directly activates Mef2
(reviewed in Castanon et al., 2001). The 175 bp early Mef2 enhancer contains
two E-box sites in Drosophila melanogaster, each of which has conserved
locations between D. melanogaster and D. virilis. Of these E-box sites, E1 is
identical in sequence between the two organisms and E2 has a differing core
sequence. In adult muscle precursors, E1 is essential for Mef2 expression
(Cripps et al. 1998). A loss in Twist binding to this site and not the others results
in loss of enhancer activity. It is, however, unknown whether Mef2 is directly
activated by Twist at the early mesodermal stage because even when E1 is
mutated, there is still weak, non-uniform expression of Mef2 in the developing
mesoderm and the enhancer is not fully active when Twist is uniformly present.
At this stage of development there may be other enhancer sequences outside
the 175 bp Mef2 enhancer that are active in adult muscle precursors (Cripps et
al. 1998). It is possible that Twist acts in combination with other factors to
regulate Mef2 throughout early mesodermal development, but this has not yet
been established. As it has been shown by Nguyen and Xu (1998), the
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mesodermal Mef2 enhancer contains binding sites for Mad/Medea transcription
factors. However, it has not been determined if these sites are important for
proper enhancer activity.
Mothers against dpp (Mad) and Medea (Med) are members of the Smad
family of transcription factors that transduce signals from receptors of the TGF-β
family proteins to promoters of target genes. Mad is an ortholog of mammalian
Smad 1/5 and Med is an ortholog of mammalian Smad4 (Massague et al. 2005,
Wisotzkey et al.1998). Smad1/5 is an example of a receptor-regulated Smad (RSmad) that interacts with Smad4, Co-Smad, upon activation by a TGF-β
receptor. This complex migrates into the nucleus and binds DNA at Smadbinding elements (SBEs) containing the core GTCT sequence via a β-hairpin
structure in one domain of the protein (Massague et al. 2005). The binding
affinity at a single SBE is too low for Smad complex binding and it has been
found that many Smad-binding promoter sequences have multiple SBEs (Shi et
al. 1998). Having multiple SBEs is likely to allow for tighter binding of the Smad
transcriptional complex and also may require additional factors in the complex to
effectively bind DNA (Seoane et al. 2004). Some Smads can also interact with
the GC rich sequence GCCGnCGC (Xu et al. 1998). The mesodermal Mef2
enhancer region has three GC-rich regions that are capable of binding Mad and
Med. It has not yet been established whether the three Mad/Med sites are
functionally important or whether there are mesodermally expressed transcription
factors, such as Twist, which can act synergistically with the Mad/Med complex
to induce Mef2 expression (Nguyen and Xu 1998).
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This study aims to determine how the transcription factors Twist, and
Mad/Med interact in the enhancer region of the Mef2 gene to regulate early
development of the mesoderm. In order to accomplish this goal, the binding
capabilities of Twist are initially verified using electrophoretic mobility shift assays
(EMSAs), whereas previously performed analyses for the Mad/Med sites have
already confirmed that Mad/Med binds to all three sites of the Mef2 enhancer
(Nguyen and Xu 1998). In vivo studies using P-element mediated germ-line
transformation are then conducted to determine the functional significance of
each of the binding sites on the Mef2 enhancer region for the developing
mesoderm. We also assess whether interaction between the transcription
factors is required for the activation of the Mef2 gene.
Materials and Methods
Generation and analysis of enhancer constructs
Transgenic DNA constructs for the Mef2 early enhancer were generated
using standard PCR methods. Primers were designed to amplify the Mef2
enhancer region. The forward primer for all enhancer constructs was 5’GGGAATTCAAGCTTGTTGGCTTGTCTTGGC. For the DM1, Twi1, and Mad3
constructs, the reverse primer was 5’-GATATTATTTACCTTAAACACGC. The
reverse primer for the DM2 construct was 5'GTTCTAACCCATATAGGAAATGATTTTGC. We used the reverse primer 5'ATGATTTTGCGCCTATTTATAC for the generation of the DM3 fragment.
Mutation in the first Twist binding site of the Mef2 enhancer was induced using
PCR-based site directed mutagenesis described by Horton et al. (Horton et al.,
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1993) changing the Twist binding site from 5'-CACATGTG to 5'CGGCCGTG.
Mutation of the three Mad/Med binding sites was performed by site-directed
mutagenesis using the GeneTailor mutagenesis kit (Invitrogen), following
manufacturer’s instructions. The Mad1 binding site (GC-3 in Nguyen and Xu,
1998), was changed from 5'-CTGTGCGCCGTACGGTTGATGCTG to 5'ATGAGCACCA, the Mad2 binding site (GC-2) was changed from 5'GCCGCCCGGC to 5'-ACCACCAGGA, and the Mad3 binding site (GC-1) was
changed from 5'-CCCTCGCCTCTCGGCGGCG to 5'ACCACGACTATCAGCAGCA.
PCR products were cloned into pCaSpeR-hsp43-AUG-β-gal (CHAB) Pelement transformation vector containing a lacZ reporter gene downstream of a
minimal hs43 heat-shock promoter (Thummel and Pirrotta, 1992). P-element
mediated germ-line transformation was performed as described by Cripps et al.,
(Cripps et al., 1999). Cloned constructs were injected into y w embryos and
transgenic lines were identified in the G1. Independent lines were maintained by
backcrossing to y w and selecting for homozygotes in subsequent generations
based on darker eye color. A minimum of three independent lines were analyzed
for each enhancer tested. Flies were raised in Carpenter’s medium at 25 oC.
Immunohistochemistry
Embryos were collected and stained as described by Patel (1994).
Primary antibodies were mouse anti-β-galactosidase 1:1000 (Promega). The
Vectastain Elite Kit (Vector Laboratories) and diaminobenzidine (DAB) stain were
used for secondary detection according to manufacturer’s instructions. Samples
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were mounted for photography using an Olympus BX51 photomicroscope with
DIC optics, after being cleared in glycerol. Images were collected digitally and
figures made using Adobe Photoshop.
Electrophoretic Mobility Shift Assay
Twist protein was generated using T7 polymerase and the TnT Coupled
Transcription/Translation system (Promega) and pAR-Twist (Cripps et al., 1998).
Two oligos of the sequence 5'-GGATGCACTCAACACATGTGCAACATGCGG-3'
and 5'-GGCCGCATGTTGCACATGTGTTGAGTGCAT-3' were annealed and the
5'-GG overhangs filled with Klenow enzyme (New England Biolabs) and (α32

P)dCTP to generate radiolabeled E1 probe DNA. Probes were purified on an

illustra Autoseq G-50 Dye Terminator Removal Kit spin column (GE Healthcare)
and 50,000 cpm were used in each assay. E2 wild-type binding site
oligonucleotides have the sequence 5'GGCGGATATACACACATGGATCGTTTGC and 5'GGGCAAACGATCCATGTGTGTATATCCG. Wild-type sequences for the E3
binding sites are 5'-GGATTTAAATGCCATATGGTAATGGCTA and 5'GGTAGCCATTACCATATGGCATTTAAAT. For competition experiments, wildtype E1 and mutant E1 oligonucleotides were used in the reactions at 100x
concentrations. E1 mutant oligonucleotides were generated in the same way
using the sequences 5'-GGATGCACTCAACACGGCGGCAACATGCGG and 5'GGCCGCATGTTGCGGCCGTGTTGAGTGCAC. Mutant E2 oligonucleotide
sequences are 5'-GGCGGATATACACCCGGGGATCGTTTGC and 5'GGGCAAACGATCCCCGGGTGTATATCCG and mutant E3 oligonucleotides are
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5'-GGATTTAAATGCGACGTCGTAATGGCTA and 5'GGTAGCCATTACGACGTCGCATTTAAAT. Electrophoretic mobility shift assays
(EMSAs) were performed using standard methods (Sambrook et al., 1989).
Binding reactions were incubated at room temperature and gels were run at a
constant temperature of 4oC. Dried gels were subjected to autoradiography.
Cell culture and transfection
For co-transfections assays, the expression plasmid pBRAcPA-Tkv was
generously provided by Michael O'Connor (University of Minnesota, Twin Cities).
We cloned Mad cDNA from the RE72705 DGRC Gold expression plasmid
(Stapleton et al., 2002) into pAW using Gateway Cloning Technology (Invitrogen)
according to manufacturer's instructions. The expression plasmid pPac-Twi was
also used in cell culture assays. Reporter constructs used for the P-element
mediated germ-line transformation were used in cell culture experiments. SL2
cells were maintained at 25oC in Schneider's Drosophila medium supplemented
with 10% heat-inactivated fetal bovine serum (FBS) (both from Invitrogen). Cells
were transfected as described in Kelly Tanaka et al. (Kelly Tanaka et al., 2008).
The ratio of transcription factor coding DNA to reporter DNA used was 1:9. DNA
was transfected into the cells using Cellfectin transfection reagent (Invitrogen).
Each treatment was transfected into two well per trial for three trials.
β-galactosidase assays
β-galactosidase assays were performed in transfected cells using a
mammalian β-galactosidase assay kit (Pierce Biotechnology) according to
manufacturer's recommendations as described in Kelly Tanaka et al. (Kelly
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Tanaka et al., 2008). Sample absorbance was read at 405 nm in an OpsysMR
multiplate reader (Dynex Technologies) warmed to 37oC. Five absorbance
measurements were taken at ten minute intervals beginning with t=0. Assay plate
remained incubating in the plate reader between measurements. Activation folds
were measured as the average of the measured β-galactosidase activity over
time, normalized to non-transfected cells. Standard error was calculated for each
activation fold and statistical comparisons between treatments were determined
by Student's t-test.
Results
Earlier studies suggested that the Mef2 enhancer that is capable of
directing expression in the entire mesoderm is located from -3572 to +521
(Cripps et al., 1998). A study by Nguyen and Xu (1998) also indicated that the
early mesoderm and dorsal mesoderm enhancers are located in smaller regions
than reported full mesoderm expression of Mef2, of sizes 280 bp and 460 bp,
respectively (Nguyen and Xu, 1998). Successive 5' and 3' deletions of the
mesoderm enhancer were performed by Cripps et al. to determine what
upstream regulatory region is necessary for expression of the Mef2 dorsal
mesoderm enhancer (Cripps et al., 1998). It was determined that a 1,059 base
pair region within the Mef2 enhancer described by Cripps et al. (1998) is
necessary for expression of Mef2 in the developing dorsal mesoderm (Figure
1A).
The 1,059-bp enhancer region was cloned into pCaSpeR-hs43-AUG-β-gal
(CHAB) and its lacZ expression was tested in the developing embryo. Mef2
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enhancer activity was present in the dorsal mesoderm (Figure 1B), and to some
extent, the early mesoderm (not shown). Interestingly, in an 848 base pair
enhancer fragment with 211 base pairs removed from the 3’ end, all expression
of the lacZ reporter was lost (Figure 1B). However, when another 20 base pairs
were removed from the 3’ end of the enhancer, some Mef2 activity was restored
in the dorsal mesoderm, but this activity was not quite as strong as that of the
1,059 bp enhancer (Figure 1B). These results suggest that the 1,059-bp
enhancer is sufficient to drive expression of the lacZ reporter. Furthermore, the
data suggest that the 211-bp at the 3' end of the enhancer is critical to enhancer
activity and that there must be a repressor within the -1593 to -1573 region of the
enhancer since enhancer activity is restored when this 20 bp region is deleted.

Figure 1: A 1,059 bp enhancer controls Mef2 expression in the dorsal mesoderm. (A) Map
of the Mef2 gene showing the location of the mesodermal enhancer (gray highlighted region).
(B) The 1,059 bp mesoderm enhancer DM1, regulates expression of Mef2 in the dorsal
mesoderm (arrow). Red circles on this map indicate the presence of E-box binding sites which
bind the transcription factor Twist. Blue circles indicate the presence of three Mad/Medea
binding sites located on the enhancer. Deletion of 211 bp from the DM1 enhancer creating an
848 bp enhancer, DM2, abolishes Mef2 expression in the mesoderm. The DM3 enhancer
contains an additional 20 bp deletion from this enhancer and restores some of the dorsal
mesoderm expression of Mef2.
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Three E box consensus sites were present in the 1,059 bp enhancer.
Although only two of the E box sites are conserved I tested the ability of the
bHLH transcription factor Twist to bind each of the sites. Twist lysate was
generated by in vitro transcription and translation. As previously reported, Twist
was able to bind specifically to the E1 binding site (Figure 2A). Unlabeled wildtype E1 probe was able compete for binding to the E1 site, but unlabeled mutant
E1 probe was not, indicating that the interaction between Twist and the E1 site
was sequence-specific. Twist was not able to bind the E2 site on the enhancer.
The E3 site was not conserved in all species of Drosophila and was therefore not
previously tested for ability to bind Twist. Our results show that Twist can bind
this site, although not as strongly as it binds the E1 site (Figure 2A). This binding
is specific since unlabeled wild-type probe can compete for Twist binding and
mutant probe is unable to bind Twist. These results indicate Twist can bind two E
box sites located on the mesodermal enhancer but that binding is stronger at the
E1 site, suggesting this is the primary binding site occupied by Twist.
To determine the functionality of the Twist binding sites, I generated an
enhancer fragment (Twi1) in which we mutated the E1 site of the 1,059 bp
construct, since Twist exhibited the highest affinity for this site. This fragment
was cloned into the CHAB vector and injected into embryos to assess Mef2
expression in this mutant construct (Figure 2B). When we analyzed lacZ
expression of this transgenic line, we observed that enhancer activity was
completely abolished by the mutation (Figure 2B). This suggested that not only is
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this binding site required for dorsal mesodermal expression of Mef2, but that the
presence of another binding site to which the Twist protein is able to directly bind,
is not sufficient to compensate for the loss of the E1 site. This E1 site is the
functional Twist binding site on the Mef2 enhancer.

Figure 2: The E1 binding site is required for Mef2 activity and directly binds Twist
protein. (A) Electrophoretic mobility shift assay (EMSA) indicates direct, specific binding of
Twist protein to the E1 and E3 binding sites of the Mef2 enhancer. Binding to the E1 site is
much stronger than binding to the E3 site. (B) Mutation of the E1 binding site on the Mef2
enhancer ablates all mesodermal enhancer activity (arrow) and reveals a requirement for
Twist binding to this site. The presence of the E2 and E3 binding sites cannot compensate
for loss of binding to the E1 site.
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Also found within this enhancer sequence are three Mad/Med binding
sites. These sites can each specifically bind both Mad and Med protein, although
the Med protein binds the Mad1 (denoted GC-3 in Nguyen and Xu, 1998) binding
site with lower affinity than Mad. Additionally, this binding site does not exhibit the
same specificity of binding Mad as do the other binding sites as it is not
competed by unlabeled Mad1 (GC-3) probe as efficiently as this competitor
probe competes with the other two sites (Nguyen and Xu, 1998).
Since Mad/Medea was able to bind all three binding sites to varying
degrees and specificities, we generated a Mef2-lacZ line termed Mad3 with all
three Mad/Med binding sites mutated to determine whether these sites are
necessary for expression of the Mef2 enhancer. These transgenic animals
maintained some of the expression observed in the non-mutated 1,059 bp DM1
enhancer, but reporter gene expression was clearly reduced (Figure 3). These
data are consistent with those reported by Nguyen and Xu in which the
expression of Mef2 is lost in mutants of the dpp signaling pathway (Nguyen and
Xu, 1998), but more importantly it demonstrates that the Dpp signal is transduced
through the identified sequences. It was suggested that residual expression of
the Mef2 enhancer in the dpp mutants could potentially be due to continued
expression from earlier stages of development.

Figure 3: Deletion of Mad/Medea binding sites on the Mef2 enhancer reduces dorsal
mesoderm expression of Mef2. Although expression of Mef2 is reduced when all three
Mad/Medea sites are mutated, expression persists in the dorsal mesoderm (arrow).
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Since Twist binds the enhancer directly and since Dpp signaling is
necessary for Mef2 enhancer activity, we examined the possibility of cooperative
interaction of these factors in activating the mesoderm enhancer in a cell culture
system. No activation for the 1,059 bp DM1 enhancer was observed for any of
the transcription factors (Figure 4A). The activation folds in this experiment were
less than 2, the threshold set by our method for activation. This is unexpected
since the enhancer is able to activate expression in the embryo. In cotransfection experiments using the DM2 enhancer (Figure 4B), as expected,
there was no activation of the DM2 enhancer as all levels for this enhancer were
below the 1.5 fold activation level. When we tested the 828 bp DM3 construct, we
saw similar activation levels with Twist and Mad alone as observed for activity
levels in the DM1 construct (Figure 4C). The presence of Twist and Mad in
combination did not result in much of a difference in the activation levels of the
enhancer. Mad phosphorylation is required for translocation of Mad into the
nucleus of the cell (reviewed in Wisotzkey et al. 1998). In order to ensure Mad
was being translocated into the nucleus we co-transfected Mad with activated
Thickveins receptor (Tkv, FBgn0003716). When we included this receptor in our
cell culture experiments, activity of the DM3 enhancer was significantly increased
from levels observed for Twist alone, Mad alone, and Twist and Mad in
combination (p<0.01). There was no difference in the activation of Twist, Mad,
and Tkv* in combination with each other from that observed when only Mad and
Tkv* are present, suggesting these factors do not act together to drive
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expression of the Mef2 enhancer. Med did not influence activation of any line
(data not shown).

Figure 4: The DM3 enhancer is activated in Drosophila SL2 cells. (A, B) Activation fold
levels for transcription factor treatments co-transfected with either the DM1 (n = 12) or DM2 (n =
6) reporter do not reach the threshold level to conclude these factors activate the enhancer. This
suggests there is no significant difference in the ability of Twist or Mad alone or together to
influence enhancer activity unless activated Thickveins (Tkv*) receptor is included in the cotransfections (A). All combinations of activators in the co-transfection experiments with the DM2
reporter were significantly different from one another and different activity with Twist or Mad
alone (B). (C) Significant activation of the enhancer was observed when Mad and Tkv* or when
Twist, Mad, and Tkv* were co-transfected with the DM3 (n = 10) enhancer. (*p<0.05, **p<0.01)
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Discussion
Precise regulation of gene activation throughout development is critical for
proper formation of many tissues and organs. Since many of the same genes are
involved in very different processes, different combinatorial interactions of protein
products must be utilized to ensure precision of spatiotemporal expression of any
given gene involved in the developmental process (Adryan and Teichmann,
2010). Mef2 is an example of such a gene that is conserved from invertebrates to
vertebrates and varies in spatiotemporal expression regulated by more than a
dozen different enhancers throughout development (Black and Olson, 1998).
One of the enhancers used in this study is a 1,059 bp enhancer, termed DM1,
which controls expression of the Mef2 gene in mesodermal tissues.
Early mesodermal expression in the developing embryos of DM1
transgenic flies is not as strong as that published by Nguyen and Xu (1998) for a
larger 4,285 bp enhancer, suggesting this enhancer is missing some region of
the Mef2 regulatory region necessary for full enhancer expression in the early
mesoderm. This region is sufficient to drive expression in the dorsal mesoderm.
When dorsoventral patterning occurs in the embryo, Mef2 expression becomes
enriched in the dorsal mesoderm (Nguyen and Xu, 1998), a region that will
eventually form the visceral mesoderm, dorsal muscle, and heart (reviewed in
Azpiazu et al., 1996).
Mef2-lacZ expression was almost entirely abrogated within the mesoderm
with an enhancer construct (DM2) that lacks 211 bp of the 3’ end of the DM1
enhancer. This suggests a region between -3,572 and -3,480 is also required for
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early mesoderm expression of Mef2 in addition to the 280 bp region reported by
Nguyen and Xu (1998). However, this conclusion is contradicted by the
observation that smaller fragments can show mesoderm-specific activity. The
DM2 construct may be less active because of a particular combination of binding
sites is present that provide a repressor activity; and when larger or small
fragments are used that alter this combination of sites the repressor activity is
lost. A putative Dorsal binding site is found in the region of the Mef2 enhancer
deleted by DM2, and it is possible that changing from two putative sites to one
putative site alters fundamentally the activity of the enhancer. Alternatively, it is
possible that the plasmid used for this study was defective in some way. While
the enhancer region inserted was sequenced for verification, perhaps a point
mutation occurred elsewhere in the plasmid, such as in the lacZ gene, which
would prevent reporter expression from being observed.
Dorsal is a sequence-specific transcription factor that binds to cisregulatory elements at the consensus sequence GGG(T)4-5CC (Pan and Courey,
1992). The primary function of Dorsal is activation of genes; however, Dorsal
can repress expression of some genes through interactions with co-repressors.
The combination of DNA-bound Dorsal and its co-repressors, mostly bHLH
proteins, can attract other repressors from the WD40 repeat protein family that
do not have DNA binding capabilities but can directly bind Dorsal protein
(Dubnicoff et al. 1997, Fisher et al., 1996, and Neer et al., 1994). When an
additional 20 bp is deleted from the Mef2 enhancer (DM3 enhancer), partial Mef2
expression is restored. Analysis of this region shows the presence of an
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additional Dorsal binding site that may be responsible for mediating restriction of
Mef2 from the ventral mesoderm at later stages.
Three E-boxes were found in the enhancer region in this study. Cripps et
al. (1998) demonstrated the requirement of the E1 site of the enhancer for Twistmediated expression in the mesoderm and the adult somatic muscle precursors
(Cripps et al., 1998). In this study, we assessed the importance of the other two
E-box sites for their roles in mesodermal Mef2 expression. Our analysis
confirmed that Twist can directly and robustly bind the E1 site and does not bind
the E2 site. Both E2 and the E3 binding site were previously untested for direct
binding of Twist. Our study shows that Twist can bind the E3 binding site but not
as robustly as the E1 site. We mutated the E1 site to test the requirement for this
site in vivo and also to test whether the E3 binding site can compensate for the
loss of the E1 site. Our results show that mutation in the E1 site eliminates Mef2
expression. This indicates that although Twist is required for Mef2 expression
and can physically bind the E3 site, this site is not necessary for activation of
Mef2 in the developing mesoderm.
The bHLH protein Twist binds to E-box consensus sequences and
mediates development of the mesoderm, regulating specification of different cell
fates within this lineage. This protein can exist in both homodimer and
heterodimer combinations facilitated by the HLH domain and different
combinations of homodimer/heterodimer interactions result in differential DNA
binding affinity, target preference, and biological activity (reviewed in Castanon et
al., 2001). The differing abilities of Twist binding to each of the three E-box
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binding sites on the Mef2 enhancer could be indicative of different bHLH factors
also being involved in regulating Mef2. Perhaps the E2 and E3 sites serve as
preferential binding sites for bHLH factors other than Twist to bind Mef2 and
regulate its expression, adding more complexity to the regulation of this
enhancer.
The results obtained from the DM1, DM2, DM3, and Twi1 enhancer
constructs suggest the Twist and Dorsal (dl, FBgn0260632) may work together to
activate the Mef2 enhancer in the mesoderm. Levine and Davidson (2005) have
discussed that Dorsal and Twist function in an additive fashion to activate genes
in the ventral mesoderm prior to gastrulation. It has also been observed that
interactions between Dorsal and bHLH transcription factors, such as Twist, can
be either in close proximity or can bind DNA at regions far from one another
(Szymanski and Levine, 1995). Twist has also been shown to directly bind the
Drosophila Toll (Tl, FBgn0262473) enhancer, possibly regulating zygotic
expression of the Toll receptor (Sandmann et al., 2007) which is required for
refining Dorsal gradients in other insects, such as Tribolium castaneum (Chen et
al., 2000). It has yet to be shown whether Twist and Dorsal act together to
promote Mef2 expression in the developing mesoderm. If there is an interaction
between the two, is the interaction a direct interaction or do the factors bind
independently of one another? It is also necessary to determine if Dorsal can
bind directly to the Mef2 enhancer and whether it acts as an activator or
repressor of Mef2.
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Nguyen and Xu (1998) showed the transcription factors Mad and Medea
can both physically bind the Mef2 enhancer at three sites. This study also
showed a requirement for Dpp signaling pathway in Mef2 expression in the
mesoderm. What was not determined was whether this dependence on Dpp
signaling resulted from the direct binding of Mad/Med to the three binding sites of
the enhancer or if Dpp signaling affected the enhancer indirectly. We created a
construct with all three Mad/Med binding sites mutated and assessed its
expression in the embryo. Our results indicate that this enhancer construct
(Mad3) maintained partial expression in the dorsal mesoderm. This could be due
to residual expression from earlier stages, as previously suggested by Nguyen
and Xu (1998), or may indicate that other transcription factors may bind these
Mad binding sites. It has been shown that the Brinker (brk, FBgn0024250)
protein can compete in vitro for binding to Mad sites on the Ultrabithorax (Ubx,
FBgn0003944) enhancer and can prevent Mad from activating Dpp targets in
vivo. Brinker is also repressed by Dpp signaling (Saller and Bienz (2001). The
possibility that this mechanism may be occurring with the Mef2 enhancer adds
complexity to the regulation of the enhancer within mesoderm development.
Due to the requirement for both Twist binding and Mad activity, we sought
to determine if these factors interact with one another in cells. Our results
showed that the only Mef2 enhancer activated in the cell culture system was the
DM3 enhancer. This enhancer was activated by the presence of Mad with an
activated Thickveins receptor and well as by these two proteins in combination
with Twist. The results from the cell culture analyses are inconsistent with the
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results obtained from our in vivo assays. This could be due to the procedure
used in our cell culture assays. For example, in these assays, we used a
reporter:activator ratio of 9:1. This ratio was the optimized ratio from experiments
where the Actin 57B (Act57B, FBgn0000044) enhancer was activated by MEF2
protein (Kelly Tanaka et al., 2008). The mesoderm is specified by morphogen
gradients that activate different gene programs in dose dependent manners,
leading to variation in the combinations of factors expressed through space and
time (Leptin et al., 1991, Xu et al., 1998, Sandmann et al., 2007, Reeves and
Stathopoulos, 2009). It is possible that by using the same 9:1 ratio of
reporter:activator, we are not addressing the complexity of the interactions
between the various factors involved in Mef2 regulation. Titrations of the different
transcription factors will be necessary to determine if there is a requirement for
differential concentrations of transcription factors for activation of theMef2
enhancer.
Additionally, as discussed earlier, many other factors could potentially play
a role in the expression patterns we observe in embryos by competing for binding
sites or by interacting with binding proteins to regulate Mef2 enhancer
expression. These levels of complexity have not been tested in our cell culture
system but possibly influence the results of these assays.
Twist activates at least 62 different targets required for mesoderm
formation (Sandmann et al., 2007). These targets could potentially affect Mef2
activation through indirect interactions with proteins that can directly bind the
enhancer. The necessity for Dpp signaling in regulation of the Mef2 enhancer
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has been demonstrated previously (Nguyen and Xu, 1998) and Mad is capable of
activating the enhancer is cell culture. However, mutation of Mad specific
binding sites does not abolish expression of Mef2 in the way dpp null mutants do.
There is also the possibility that Dorsal protein may be acting to both activate and
repress Mef2 expression. Further optimization of our Mef2 enhancer for activity in
cell culture is necessary before any solid conclusions can be made regarding the
interactions of these proteins. It would also be useful to determine if Dorsal binds
this enhancer and if any or all of these factors can occupy the enhancer
simultaneously.
It is necessary for Mef2 to be precisely regulated throughout development
since it is required for proper mesoderm specification and for differentiation of all
lineages of muscle. The full complexity of regulation, while extensively studied,
remains poorly understood (reviewed in Black and Olson 1998, reviewed in
Ciglar and Furlong, 2009). MEF2 is an evolutionarily conserved protein that
affects many cellular and developmental processes from yeast to vertebrates
(reviewed in Potthoff and Olson, 2007). Understanding the processes involved in
regulating the diverse functions of Mef2 within Drosophila can guide future
studies in vertebrate models where redundancy caused by multiple Mef2 genes
can confound analysis.
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SUMMARY
Mechanisms of muscle development are conserved in invertebrates and
vertebrates. For this reason, Drosophila melanogaster is a model organism well
suited for the study of such mechanisms. The utility of this model organism also
makes it amenable to the types of molecular and genetic analysis that allows
researchers to understand the very basal mechanisms involved in these
developmental processes from general to cell-specific regulation. The genes that
regulate the development of muscle precursors and mature muscle fibers are
shown to have functions in other invertebrates and most vertebrate species.
In this dissertation, the gene CG14614 was identified as a gene required
for the formation of the neuromuscular junction between the Tergal depressor of
trochanter (TDT) muscle and the Posterior dorsal mesothoracic nerve (PDMN),
which innervates this muscle. In the absence of this innervation, as observed in
wings apart (wap) mutants, the TDT muscle degenerates within 24 hours after
the onset of metamorphosis.
The protein encoded by CG14614 exhibits a conserved function in
vertebrates. This is demonstrated by the observation that CG14614 protein can
functionally rescue a severe craniofacial defect observed in the zebrafish wdr68
mutant. This is very striking observation since vertebrate craniofacial
development occurs in tissues that are absent in Drosophila. The protein has
also been isolated from rabbit skeletal muscle, complexed with Dyrk proteins that
are encoded by genes that also have a Drosophila ortholog, minibrain (mbn).
Based upon these observations, it would be interesting to determine if there is a
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functional interaction between CG14614 and mbn and if such an interaction is
required for proper formation of the neuromuscular junction.
In addition to the identification of CG14614 as the gene responsible for the
wap mutation, we were also able to identify the gene CG14619 as the gene
affected by a mutation known as introverted (intro). This gene is likely an
ecdysone response gene and functions in the process of head eversion as well
as wing and leg disc extension. This gene may also function in either the
development or maintenance of the abdominal muscles, since contractions of the
abdominal muscles in response to pulses of ecdysone are required for proper
head eversion in the fly.
Regulation of the Mef2 dorsal mesoderm enhancer was also analyzed for
the requirement of interactions of Twist, Mad, and Medea binding. Twist is
required for Mef2 activation. Although a requirement for Dpp signaling has
previously been demonstrated for expression of the Mef2 enhancer, mutation of
the binding sites to which Mad and Med bind does not completely abolish
expression. The presence of two putative Dorsal binding sites on the enhancer
suggest there may be a dual activator-repressor role for Dorsal in the regulation
of the mesodermal Mef2 enhancer. Further investigation is necessary to assess
the added complexity of Mef2 regulation highlighted by this study.
Since the factors regulating specification of the mesoderm and the
somatic muscle are conserved across many animal groups, the principles guiding
the general developmental process can most likely be extrapolated from simple
invertebrate organisms to more complex organisms, such as humans, where
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study of these mechanisms is far more challenging and complex. The research
presented in this dissertation is intended to shed light on such mechanisms in
order to gain a better understanding of both vertebrate muscle formation and the
diseases affecting these muscles.
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